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ABSTRACT OF DISSERTATION

ASSESSMENT OF WHITE MATTER HYPERINTENSITY, CEREBRAL BLOOD
FLOW, AND CEREBRAL OXYGENATION IN OLDER SUBJECTS STRATIFIED
BY CEREBROVASCULAR RISK
Objective: Cerebrovascular disease (CVD) is the fifth most common cause of
mortality in the United States. Diagnosis of CVD at an early stage is critical for optimal
intervention designed to prevent ongoing and future brain injury. CVD is commonly
associated with abnormalities of the cerebral microvasculature leading to tissue
dysfunction, neuronal injury and death, and resultant clinical symptoms, which in turn,
further impacts cerebral autoregulation (CA). This series of studies aims to test the
hypothesis that white matter hyperintensities (WMH) and cerebral hemodynamics
(quantified by magnetic resonance imaging (MRI) and an by innovative hybrid nearinfrared diffuse optical instrument) can be used as biomarkers to distinguish cognitively
healthy older subjects with high or low risk for developing CVD.
Methods: Using functional MRI, WMH and cerebral blood flow (CBF) were
quantified in 26 cognitively healthy older subjects (age: 77.8 ± 6.8 years). In a follow-up
study, significant variability in WMH quantification methodology was addressed, with
sources of variability identified in selecting image center of gravity, software compatibility,
thresholding techniques, and manual editing procedures.
Accordingly, post-acquisition processing methods were optimized to develop a
standardized protocol with less than 0.5% inter-rater variance. Using a novel laboratorymade hybrid near-infrared spectroscopy/diffuse correlation spectroscopy (NIRS/DCS) and
a finger plethysmograph, low-frequency oscillations (LFOs) of CBF, cerebral oxygenation,
and main arterial pressure (MAP) were simultaneously measured before, during, and after
70° head-up-tilting (HUT). Gains (associated with CAs) to magnify LFOs were determined
by transfer function analyses with MAP as the input and cerebral hemodynamic parameters
as the outputs. In a follow-up study, a fast software correlator for DCS and a parallel
detection technique for NIRS/DCS were adapted to improve the sampling rate of hybrid
optical measurements. In addition, a new DCS probe was developed to measure CBF at the
occipital lobe, which represents a novel application of the NIRS/DCS technique.
Results: MRI measurements demonstrate that deep WMH (dWMH) and
periventricular WMH (pWMH) volumetric measures are associated with reduced regional
cortical CBF in patients at high-risk of CVD. Moreover, CBF in white matter (WM) was
reduced in regions demonstrating both pWMH and dWMHs. NIRS/DCS optical
measurements demonstrate that at resting baseline, LFO gains in the high-risk group were
relatively lower compared to the low-risk group. The lower baseline gains in the high-risk
group may be attributed to compensatory mechanisms that allow the maintenance of a
stronger steady-state CA. However, HUT resulted in smaller gain reductions in the highrisk group compared to the low-risk group, suggesting weaker dynamic CA in association
with increased CVD risks. A noteworthy finding in these experiments was that CVD risk
more strongly influenced CBF than cerebral oxygenation.

Conclusions: Regional WMH volumes, cortical and WM CBF values, and LFO
gains of cerebral hemodynamics demonstrate specific associations with CA and may serve
as important potential biomarkers for early diagnosis of CVD. The high spatial resolution,
large penetration depth, and variety of imaging-sequences afforded by MRI make it an
appealing imaging modality for evaluation of CVD, although MRI is costly, time-limited,
and requires transfer of subjects from bed to imaging facility. In contrast, low-cost,
portable, mobile diffuse optical technologies provide a complementary alternative for early
screening of CVD, that can further allow continuous monitoring of disease attenuation or
progression at the subject’s bedside. Thus, development of both methodologies is essential
for progress in our future understanding of CVD as a major contributor to the morbidity
and mortality associated with CVD today.
KEYWORDS: Near-infrared Spectroscopy/Diffuse Correlation Spectroscopy, Magnetic
Resonance Imaging, Cerebrovascular Diseases, White Matter Hyperintensities, LowFrequency Oscillation, Cerebral Blood Flow and Oxygenation.
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INTRODUCTION
1.1

Cerebrovascular Disease (CVD)
Cerebrovascular disease (CVD) is a global term for cerebrovascular injuries that may

arise from a variety of different causes. CVD in the aging population is most commonly
due to cerebral small vessel ischemic disease (CSVD), although both lacunar and large
vessel ischemic infarcts contribute significantly as well as microvascular infarcts, cerebral
amyloid angiopathy, and overt subcortical and cortical hemorrhagic stroke [1]. CVD is the
fifth most common cause of mortality in the United States (0.14 million in 2017) [2, 3],
and the second worldwide (17.6 million in 2016) [4]. Risk factors for CVD include aging,
atherosclerosis, smoking, hypertension, high cholesterol, and diabetes, among others [58]. Advanced age represents the major risk factor for the development of CVD, irrespective
of cause [9]. The present dissertation will focus on the development of new and refined
biomarkers to detect CSVD, which is a major cause of the cognitive decline and loss of
function in the aging population today [10].
CSVD is a general term that refers to injury affecting the cerebral arterioles, venules,
capillaries, and small vessels through a variety of pathological processes. These
pathological processes are thought to contribute to approximately 45% of the total burden
of dementia seen in the aging population today [11]. CSVD is considered the most
prevalent cause for the development of vascular dementia, which is regarded as the second
most common type of dementia in the United States [12, 13] after Alzheimer’s disease
(AD) according to the Alzheimer’s Association (https://www.alz.org/alzheimersdementia/what-is-dementia).

Cerebral

blood

flow

(CBF)

impairment,

cerebral

microbleeds, micro-and other small vessel infarcts, and lacunar infarctions, all lead to
1

increased white matter hyperintensities (WMH) seen on magnetic resonance imaging
(MRI) derived T2 sequences. Beta-amyloid, associated with the development of AD, can
also lead to vascular abnormalities via aggregation within small vessels and capillaries that
may be responsible for some of the WMH seen in routine imaging studies suggesting that
CSVD may not be due solely to traditional cerebrovascular disease risk factors (Fig. 1-1).

2

Figure 1-1: A schematic diagram focuses on the pathogenesis of CSVD that results in
irreversible brain injury.
This diagram is modified from the prior work of Leonardo Pantoni [1]. The cartoon
diagram highlights the leading causes of cerebral autoregulation failure, with resultant
WMH, and microbleeds, and the techniques that were used in these studies (black blocks).

3

1.2

Noninvasive Diagnosing Techniques for Cerebral Small Vessel Disease
The diagnosis of CSVD in its earliest stage is considered critical in regard to the

timing of interventions that may prevent further complications. Ideal diagnostic tests
should be noninvasive, low-cost, and have high diagnostic accuracy for CSVD even in the
earliest clinical or preclinical stages of the disease. Several techniques have been used to
study CSVD. Alternative means to assess CSVD include pathological assays that may be
invasive, as they are dependent on the collection of blood or cerebral spinal fluid (CSF)
[14].
Neuroimaging is a critical tool for diagnosing neurodegenerative disease states
[15], such as vascular dementia and Alzheimer’s disease. WMH can be visualized through
MRI imaging sequences and CT-scan although MRI with fluid attenuated inversion
recovery (FLAIR) sequence has a higher contrast [16]. Moreover, CT-scan has noise
artifacts at the regions that close to the bone structures as well as the ionized radiation risk
issue [17]. Thus, MRI is more recommended than CT-scan for diagnosing WMH lesions.
CBF can be quantified using a wide range of techniques including positron
emission tomography (PET) [18], single positron emission computed tomography
(SPECT) [19], and noninvasive arterial-spin-labeling (ASL) MRI [20]. Although PET and
SPECT techniques are considered gold standard techniques for imaging CBF [21, 22], both
require injection of a radioactive contrast agent that has side effects [18, 19].
Transcranial Doppler ultrasound (TCD) has been used to measure cerebral blood
flow velocity (CBFV) in major arteries, which may not be consistent with CBF in the
microvasculature [23]. Moreover, TCD cannot be performed in ~10% of subjects who do
not have adequate acoustic windows [24].
4

Spectral techniques have been used for the detection of CSVD, including diffusion
correlation spectroscopy (DCS) for CBF measurement [25, 26], and near-infrared
spectroscopy (NIRS) for cerebral oxygenation measurement [27]. Since CBF and cerebral
blood oxygenation are usually coupled and interactive, it is desirable to measure both
quantities and investigate their complicated relationship.
In summary, the high spatial resolution, large penetration depth, and variety of
imaging-sequences afforded by MRI make it an appealing imaging modality for evaluation
of CSVD, although MRI is costly, time-limited, and requires transfer of subjects from bed
to imaging facility. In contrast, low-cost, portable, mobile NIRS/DCS diffuse optical
technologies provide a complementary alternative for early screening of CSVD, that can
further allow continuous monitoring of disease attenuation or progression at the subject’s
bedside. Thus, development of both methodologies is essential for progress in our
understanding of CSVD as a major contributor to the morbidity and mortality associated
with CVD.
1.3

Chapter Organization
This dissertation consists of six chapters that are organized as follows:
Chapter 1 presents an introduction to basic concepts necessary to understand CVD

and the historical context and techniques that have been used for diagnosing and studying
CSVD.
Chapter 2 presents a study with functional MRI that aims to add clarity to the
relationship between deep and periventricular brain WMHs, CBF, and cerebrovascular risk
in older persons. Deep and periventricular WMHs and regional gray matter (GM) and
white matter (WM) blood flow from arterial spin labeling were quantified from MRI scans
5

of 26 cognitively normal older subjects stratified by CVD risk. FLAIR images were
acquired using a high-resolution 3-dimensional (3D) sequence that reduced partial volume
effects seen with slice-based techniques. Deep WMHs but not periventricular WMHs were
increased in patients at high risk of CVD; periventricular WMHs but not deep WMHs were
associated with decreased regional cortical GM blood flow. We also found that blood flow
in WM was decreased in regions of both periventricular WMH and deep WMH, with a
greater degree of decrease in periventricular WMH areas. WMHs are usefully divided into
deep WMH and periventricular WMH regions because they demonstrate differential
associations with the experimental variables studied and have discrete implications for
human disease related to CVD risks. We conclude that 3D regional WMH volume is a
potentially valuable marker for CSVD based on the demonstrated associations with
cortical and WM CBF.
Chapter 3 focuses on methodologic improvements for the post-processing
volumetric analytic protocols that were introduced in Chapter 2. Disparate research sites
using identical or near-identical MRI acquisition techniques often produce results that
demonstrate significant variability regarding volumetric quantification of WMH in the
aging population. The sources of such variability have not previously been fully explored.
3D FLAIR sequences from a group of randomly selected aged subjects were analyzed to
identify sources-of-variability in post-acquisition processing that can be problematic when
comparing WMH volumetric data across disparate sites. The methods developed focused
on standardizing post-acquisition protocol processing methods to develop a protocol with
less than 0.5% inter-rater variance. A series of experiments using standard MRI acquisition
sequences explored post-acquisition sources-of variability in the quantification of WMH

6

volumetric data. Sources-of-variability included: the choice of image center, software suite
and version, thresholding selection, and manual editing procedures (when used).
Controlling for the identified sources-of-variability led to a protocol with less than 0.5%
variability

between

independent

raters

in

post-acquisition

WMH

volumetric

quantification. Comparison with existing method(s): Post-acquisition processing
techniques can introduce an average variance approaching 15% in WMH volume
quantification despite identical scan acquisitions. Understanding and controlling for such
sources-of-variability can reduce post-acquisition quantitative image processing variance
to less than 0.5%. Considerations of potential sources-of-variability in MRI volume
quantification techniques and reduction in such variability is imperative to allow for
reliable cross-site and cross-study comparisons.
Chapter 4 presents a low-frequency oscillation (LFO) method to test whether the
cerebral autoregulation (CA) can be used as a biomarker to distinguish two groups of
cognitively intact older adults with high or low risk for developing CVD. A novel hybrid
near-infrared diffuse optical instrument and a finger plethysmograph were used to
simultaneously detect LFOs of CBF, oxy-hemoglobin concentrations ([HbO2]), and
deoxy-hemoglobin concentrations ([Hb]), and main arterial pressure (MAP) in older adults
before, during, and after 70° head-up-tilting (HUT). LFOs were quantified in 4 frequency
intervals: I (0.005-0.0095 Hz), II (0.0095-0.02 Hz), III (0.02-0.07 Hz), and IV (0.07-0.2
Hz). The LFO transfer function gains were determined by transfer function analyses with
MAP as the input, and CBF, [HbO2] and [Hb] as the outputs. In general, CAs correlate
inversely with LFO gains. At resting baseline, LFO gains in the high-risk group (n = 11)
were relatively lower compared to the low-risk group (n = 13). Particularly at Interval-IV,
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intergroup gain differences reached significance for all measured cerebral variables (CBF,
[HbO2] and [Hb]). The lower baseline gains in the high-risk group may attribute to
compensatory mechanisms to maintain stronger steady-state CAs. However, HUT resulted
in smaller gain reductions at Interval-III and Interval-IV in the high-risk group compared
to the low-risk group, suggesting weaker dynamic CAs. In addition, cerebrovascular risk
was a stronger predictor of CBF than of [HbO2] and [Hb]. Cerebrovascular risk affects
neurogenic and myogenic activities (Interval III and Interval-IV) more than endothelial
activities (Interval-I and Interval-II). LFO gains are potentially valuable biomarkers for
early detection of CSVD based on associations with CAs.
Chapter 5 focuses on the methodologic improvements of NIRS/DCS techniques
that were presented in Chapter 4. The improved NIRS/DCS technologies with parallel
detection, high sampling rates, and new probe design allow us, for the first time, to measure
both CBF and cerebral oxygenation at frontal and occipital lobes in two order subjects.
Chapter 6 presents a summary of this dissertation and points out future
perspectives. This thesis includes a diverse set of work and experiments with a primary
focus on improving optical measurement techniques and developing MRI post-processing
imaging protocols that maximize our potential for the future study of CSVD.
Overall, the main focus of this dissertation was to test whether WMH and cerebral
hemodynamics quantified respectively by the MRI and hybrid NIRS/DCS can be used as
biomarkers to distinguish two groups of cognitive healthy older subjects who evaluated as
high or low risk for developing CVD. We demonstrated WMH volumes based on
associations with cortical and WM CBF values and LFO gains of cerebral hemodynamics
based on associations with CAs are potential biomarkers for early detection of CVD.
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WHITE MATTER HYPERINTENSITIES ASSOCIATIONS WITH
CEREBRAL BLOOD FLOW IN OLDER SUBJECTS STRATIFIED BY
CEREBROVASCULAR RISK
2.1

Introduction
Cerebrovascular disease (CVD) is a common medical morbidity in the United States,

with high rates of disability through stroke and dementia [28, 29]. Detection and
characterization of existing cerebrovascular disease, therefore, remains an important
medical issue. An understudied aspect of cerebrovascular disease is the relationship
between cerebral blood flow (CBF) and white matter hyperintensities (WMH, [30, 31]).
WMH are periventricular and deep regions of abnormal signal commonly seen on MRI
scans of older and high vascular risk patients [32, 33]. It has been found that WMH embody
an ischemic component with functional consequences including cognitive decline and
dementia, but due to the underlying complexity of these lesions a full formulation of their
significance has not been achieved [34, 35]. In this study we analyzed the relationship
between WMH and CBF in subjects stratified by cerebrovascular risk. The aim of this
study was to find relationships between WMH, CBF and CSVD risk, expecting that WMH
would increase with increased CSVD risk and with decreased CBF.
2.2
2.2.1

Materials and Methods
Participants
Twenty-six healthy subjects were recruited by the Center for Clinical and

Translational Science (CCTS) and the Sanders-Brown Center on Aging at the University
of Kentucky. Written consent was obtained from each individual before participation
Published Study: Bahrani et.al, Journal of Stroke and Cerebrovascular Diseases, 26 (4),
779–786 (2017)

according to an approved protocol from the Institutional Review Board (IRB) at the
University of Kentucky.
A CVD risk score, based on Framingham risk estimation modified for stroke
prediction [36], was assigned to each patient by study neurologists. The Framingham study
risk score is based on several parameters, e.g., gender, age, history of diabetes, blood
pressure, smoking history, and cholesterol level, and used to predict CVD over ten years
for each subject. The Framingham scoring scale range is 1 - 30 points. Subjects were
divided, based on their risk score, into two groups: high-risk (n = 12) and low-risk (n = 14)
for CVD, based on a cutoff of 15 points. Image analysis was blind to age and CVD risk
status.
2.2.2

MRI Acquisition
A Siemens 3T TIM Trio MRI scanner at the University of Kentucky magnetic

resonance imaging and spectroscopy center (MRISC) equipped with a 32-channel head
coil was used to scan subjects. Acquisition sequences were: (1) T1-weighted
magnetization-prepared rapid acquisition gradient echo (MPRAGE), echo time (TE) 2.3
ms, repetition time (TR) 2530 ms, inversion recovery time (IR) 1100 ms, flip angle (FA)
is 7º, 1 x 1 x 1 mm resolution full brain coverage (2) Fluid attenuated inversion recovery
(FLAIR), TE 388 ms, TR 6000 ms, IR is 2200 ms, 3D 1 x 1 x 1 mm with no gap between
slices, and (3) Pulsed arterial-spin-labeling (PASL) TE 12 ms, TR 3400 ms, IR1 700 ms,
IR2 1900 ms, 4 x 4 x 4 mm resolution with 1 mm gap between slices, full brain coverage
excluding the cerebellum.
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2.2.3

Image Processing
MRI image processing used semi-automated methods to quantitate regional WMH

volume and CBF flow values. These methods are summarized in Fig 2-1. Two images
were registered and averaged to increase the signal-to-noise ratio. Scalp and bone tissue
were stripped using the FSL FMRIB software library (FSL v5.0.8) Brain extraction tool
(BET) (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/BET). Slice by slice cleanup of unwanted
tissue was performed using the medical image processing analysis and visualization
(MIPAV v7.2.0) application (http://mipav.cit.nih.gov). The stripped brain image was
converted to a mask by thresholding (brain mask). FLAIR and PASL images were
registered to the image in SPM12 (http://www.fil.ion.ucl.ac.uk/spm) and stripped of
extraneous tissue using the brain mask.

Figure 2-1: Diagrammatic overview of the processing workflow for quantitating WMH
and cerebral blood flow using FLAIR and arterial spin-labeling images.
Segments: C1: gray matter; C2: WM tissue class 1; C3: cerebrospinal fluid; C7: WM tissue
class 2. Abbreviations: FLAIR, fluid-attenuated inversion recovery; MPRAGE,
magnetization-prepared rapid-acquisition gradient echo; WM, white matter; WMH, white
matter hyperintensity.
11

Multimodal segmentation was performed on masked, FLAIR and ASL brain
images in the SPM12 unified regime to create separate native-space images representing
grey matter (GM; Fig 2-2a), white matter (WM) and cerebrospinal fluid (CSF) using an
in-house segmentation template created from 145 images of normal subjects. WM was
modeled as two separate tissue classes to represent variations due to WM intensities [37].
The international consortium for brain mapping (ICBM) atlas reference was registered to
the segmentation template, and atlas regions combined to create masks representing the
frontal, temporal, parietal and occipital brain regions for both GM (Fig. 2-2b) and WM
(Fig. 2-2c).
2.2.4

Cerebral Blood Flow (CBF) Quantification
The ICBM lobar masks were registered to each subject’s native-space ASL image

using the inverse transform generated during segmentation. Median CBF values were
extracted from each grey matter template region (Fig. 2-2d).
(a)

(b)

(c)

(d)

Figure 2-2: Gray matter and white matter masks.
(a) Native-space GM segmented image. (a and c) International Consortium for Brain
Mapping template masks of white matter and GM transferred to the standard space of the
subject (compare with a). (d) GM template masks applied to the registered arterial spinlabeling image. Abbreviation: GM, gray matter.
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2.2.5

White Matter Hyperintensity (WMH) Quantification
The two WM segmentation images (Fig. 2-3a and Fig. 2-3b) were summed (Fig.

3c) and converted to a binary WM mask in native space (Fig. 2-3d). In a few instances
WM voxels were misclassified in an extraneous tissue segment, likely due to partial
volume effects; in these cases, these voxels were added to the two WM segments before
(a)

(e)

(b)

(f)

(c)

(d)

(g)

(h)

Figure 2-3: Sequential steps of the segmentation process to quantitate WMH.
(a and b) Segmented images representing 2 tissue classes of WM; (c) total WM (a + b);
(d) WM mask from thresholding of (d); (e) FLAIR image; (f) FLAIR image masked by
d (FLAIR, WM voxels); (g) histogram of (e) showing Gaussian fit and threshold of 3.0
standard deviation (arrowhead); (h) WMH image obtained by applying threshold to (f).
Abbreviations: FLAIR, fluid attenuated inversion recovery; WM, white matter; WMH,
white matter hyperintensity.
binary conversion. The unitary WM mask isolated WM in the FLAIR image (Fig. 2-3e)
by multiplication, (Fig. 2-3f). The Gaussian fit to the histogram of WM voxels was used
to set the threshold for WMH (Fig. 2-3g), as the mean plus 3 x SD, corresponding to a pvalue of 0.01. The threshold values were applied to each FLAIR image and 1 mm Gaussian
filtered to remove noise, creating a WMH image for each subject (Fig. 2-3h).
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A final quality-control procedure used a high-contrast display of the FLAIR image
at the Gaussian-fit mean center and window value of 10 x standard deviation (SD), side by
side with the WMH image, comparing slice by slice for correspondence between isolated
WMH and FLAIR hyperintensities. Manual editing of extraneous pixels due to pulsation
and flow artifacts was needed occasionally, resulting in the final WMH image (Fig. 2-3h),
quantitated by calculating total voxels and total WMH voxel volume [37]. Voxels in the
WMH image were divided into pWMH and dWMH using the following method designed
to produce a reproducible and consistent definition of pWMH and dWMH: (1) the CSF
segment (Fig. 2-4a) was used to generate a mask by thresholding at 0.33 (Fig. 2-4b).
Connected voxels were morphologically identified as belonging to ventricles (Fig. 2-4c)
and isolated (Fig. 2-4d). The ventricular volume was intensity-inverted (Fig. 2-4e) and
multiplied by the FLAIR image (Fig. 2-4f) to exclude the CSF (Fig. 2-4g), (2) the border
(a)

(b)

(c)

(h)

(i)

(j)

(d)

(k)

(e)

(f)

(l)

(m)

(g)

(n)

Figure 2-4: Sequential steps in obtaining deep WM and periventricular WM binary masks.
(a) CSF isolated from other tissues. (b) Binarized CSF. (c) Ventricular CSF cluster
identified. (d) Ventricular tissue voxels. (e) Reversing the intensity of (d) and multiplying
by fluid-attenuated inversion recovery image (f) to remove the CSF (g). (h) The edge of
(d) that is dilated by 5 × 5 × 5 voxels (i). (i) and (g) are multiplied to obtain the
periventricular tissue (j), which is converted to a binary image (k). (l) WMH image;
multiply by (k) once and the reverse intensity of (k) once to obtain periventricular WMH
and deep WMH, respectively (m and n). Abbreviations: CSF, cerebrospinal fluid; WM,
white matter; WMH, white matter hyperintensity.
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of the ventricular mask was morphologically identified (Fig. 2-4h) and dilated (53 voxels;
Fig. 2-4i), then multiplied by the CSF-excluded FLAIR image to identify periventricular
tissue (Fig. 2-4j). Ten percent of the mean value from periventricular tissue voxel
histogram was set as minimum threshold level to obtain the periventricular binary mask
(Fig. 2-4k), and (3) this mask was multiplied by the total WMH mask (Fig. 2-4l; cf. Fig.
2-3h) to obtain pWMH (Fig. 2-4m), and the negative of this periventricular binary mask
multiplied by the total WMH mask to obtain dWMH (Fig. 2-4n).
2.2.6

Statistical Methods
Multivariate analysis of variance (MANOVA) models used log-transformed

measured WMH volumes as repeated independent variables because of their typical
skewed distributions (JMP v9, SAS Institute). Dependent variables were risk group (high
versus low vascular risk) and total intracranial volume (TIV) to control for head size. Post
hoc contrasts of dWMH and pWMH versus risk group relationships were performed. A
similar model was used for ASL cerebral blood flow in three defined WM regions: the two
containing either dWMH or pWMH, and one without WMH. Age, risk group and TIV
were used as covariates in this model. To test relationships between dWMH and pWMH,
a standard least squares model was constructed with log dWMH as the dependent variable,
and risk group nested within log pWMH as independent variables, with TIV as control for
head size. A p-value of 0.05 was considered significant; a p-value < 0.10 marginally
significant.
2.3

Results
The 26 subjects had a mean age of 77.8 ± 6.8 years (range 66 - 88). There were

twenty-three females (mean age 77.8 ± 6.9) and three males (mean age 77.0 ± 7.9). There
15

(a)

(b)

Figure 2-5: White matter hyperintensity volume results.
(a) Linear regression of Longstreth visual rating scale (0-9) for all patients on log WMH
total volume, demonstrating the face validity of the WMH volume measurement
(adjusted r2 = 0.88, p-value < 0.0001), (b) log WMH volume in low- and high-risk
groups; overall volume is higher in high-risk patients (p-value = 0.02), but only the
dWMH volume is significant (*p-value = 0.03, error bars = standard deviation).
Abbreviations: dWMH, deep white matter hyperintensity; pWMH, periventricular
white matter hyperintensity; WMH, white matter hyperintensity.
was a significant difference in age between risk groups: the low-risk group had a mean age
of 72.7 ± 4.2 and the high-risk group had a mean age of 83 ± 4.6 (p < 0.0001).
2.3.1

White Matter Hyperintensities
Total WMH volume positively correlated with independent visual ratings using the

Longstreth scale [38], confirming that volumes correspond to what a trained neurologist
interprets as WMH (Fig. 2-5a). There was a significant correlation between pWMH and
dWMH in the regression model, but the relationship between pWMH and dWMH was
different for high and low-risk subjects: the slope of regression was higher in the high-risk
group (1.26 ± 0.22 SE; t = 5.5, p-value < 0.0001) compared to low-risk (0.86 ± 0.34, t =
2.5, p-value = 0.02). The mean dWMH volume was higher in the high-risk group compared
to low risk (t = 2.3, p-value = 0.03; Fig. 2-5b).
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MANOVA analysis confirmed that WMH volume was higher in the high-risk
group (F = 5.8, p-value = 0.02). Further analysis demonstrates that dWMH volume was
higher in the high-risk group (t = 2.2, p-value = 0.04), but pWMH volume was not
significantly different (t = 1.0, p-value = 0.34) between groups. Age correlated with total
WMH (p-value = 0.04) and dWMH (p-value = 0.03) but not pWMH volume (p-value =
0.10). There was a strong correlation seen between age and risk score (r2 = 0.56; p-value <
0.0001).
2.3.2

Cerebral Blood Flow
There were no differences in global or in regional cortical GM CBF between risk

groups. There was no association between CBF and age. We analyzed associations
between WMH volume and regional CBF. Results are shown in Table 2-1. Correlations
were significant between parietal WMH volume and posterior frontal, parietal, temporal,
and occipital CBF, and marginally significant with total CBF. Occipital pWMH volume
was significantly correlated with CBF in the medial temporal GM (Table 2-1).
Table 2-1 Spearman rank correlations for the pWMH and CBF for different brain
regions
Temporal
Mean
Frontal Frontal
Occipital Parietal Temporal
Total
(SD)
(Ant.) (Post.)
(Medial)
Total
WMH
Frontal
Occipital
Parietal
Temporal

-0.28
(0.15)
-0.16
(0.41)
-0.06
(0.73)
-0.34
(0.08)
-0.13
(0.49)

-0.16
(0.41)
-0.16
(0.41)
0.13
(0.50)
-0.28
(0.15)
0.004
(0.98)

-0.33
(0.09)
-0.24
(0.23)
-0.006
(0.97)
-0.39
(0.04) §
-0.09
(0.63)

-0.37
(0.06)
-0.21
(0.29)
-0.08
(0.66)
-0.39
(0.04) §
-0.23
(0.24)
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-0.37
(0.06)
-0.17
(0.37)
-0.07
(0.72)
-0.44
(0.02) §
-0.18
(0.36)

-0.37
(0.06)
-0.23
(0.23)
-0.25
(0.19)
-0.38
(0.05) §
-0.23
(0.24)

-0.31
(0.11)
-0.25
(0.20)
-0.42
(0.03) §
-0.30
(0.13)
-0.29
(0.14)

Average white matter CBF was calculated for three WM regions containing
dWMH, pWMH or neither lesion (F = 53.5, p-value < 0.0001; Fig. 2-6). Age, risk group
and TIV did not significantly affect CBF. Post-hoc paired comparisons showed
significantly decreased CBF in dWMH (t = 5.7, p-value < 0.001) and pWMH (t = 11.0, pvalue < 0.0001) regions compared to normal appearing white matter. CBF in pWMH was
less than in dWMH areas (t = 3.1, p-value = 0.003).

Figure 2-6: Arterial spin-labeling blood flow in the WM (left to right).
Total WM including WMH, total WM but excluding WMH, dWMH regions, and pWMH
regions. Paired comparisons are significantly different as shown. Lowest CBF is in the
pWMH regions. Bar height: mean CBF; error bars: standard deviation. Abbreviations:
CBF, cerebral blood flow; dWMH, deep white matter hyperintensity; pWMH,
periventricular white matter hyperintensity; WM, white matter; WMH, white matter
hyperintensity.
2.4

Discussion
The aim of this study was to find relationships between WMH, CBF and CVD risk

in older patients. CVD risk was assessed by the Framingham CVD stroke risk score
assigned to each patient. Fourteen subjects with low-risk were compared to twelve subjects
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with high-risk. We used a 3D FLAIR WMH imaging technique that improved resolution
and registration and reduced partial volume effects compared to slice-based techniques.
The main findings are that dWMH but not pWMH are increased in high-risk patients, and
that pWMH but not dWMH are associated with decreased regional cortical GM blood
flow. We also found blood flow in white matter is decreased in regions of both pWMH
and dWMH, with a greater degree of decrease in pWMH areas.
The underlying origin of WMH remains controversial, perhaps because different
mechanisms responsible for their appearance and pathologies can be found at autopsy that
so far are not distinguishable using current MRI methods [29, 34, 39-45]. The strongest
and most consistent associations with WMH are age and certain cerebrovascular risk
factors including diabetes, hypertension, hypercholesterolemia, and cigarette smoking [35,
36, 46-53]. These factors are included in vascular risk measures such as the Framingham
score used in this study. A genetic component may be involved in cases where evidence
of CVD is lacking [54-58].
Age associations with WMH are likely explained by the accumulation of vascular
disease over time together with other changes in cerebral white matter that may be
unrelated to small vessel cerebrovascular disease per se, such as cerebral amyloid
angiopathy or AD-related changes [59, 60]. Nonetheless, WMH are taken with much
supporting evidence to represent a marker of classical small vessel cerebrovascular disease
in white matter. CSVD is increasingly recognized as an important pathological contributor
to clinical decline in our aging US population, showing strong associations with both gait
disorders and vascular dementia [10, 61, 62]. Vascular dementia can occur as a pure form,
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or often together with more common dementias including Alzheimer’s disease (where it is
termed mixed vascular dementia) [63].
We divided WMH into dWMH and pWMH for several reasons [37, 64-68]. First,
the white matter tracts adjacent to the ventricles encompassed by pWMH are limbic
(cingulum) and motor (corticospinal and related tracts), whereas dWMH are more likely
to involve long association tracts and thus long-range inter-regional connectivity. The
possibility that clinical correlates of dWMH and pWMH may be different is also supported
by the association of dWMH but not pWMH with vascular dementia [37, 69]. Finally, the
small-vessel circulation in white matter may be different between deep and periventricular
zones, with a greater vulnerability of the periventricular region to large-vessel disease [70].
This is consistent with our finding that low cortical CBF is associated with greater pWMH.
We found that the relationship between pWMH and dWMH was different
depending on risk group: the increase in dWMH per given change in pWMH was higher
in the high-risk group, even though pWMH volume was the same. This suggests that
vascular risk factors are associated with more widespread small vessel disease in white
matter, whether directly or indirectly via large vessel flow compromise. Other evidence of
CVD in our data was decreased white matter CBF in both dWMH and pWMH regions.
However, these differences were not related to age or to CVD risk status.
There are several caveats to the interpretation of our data. The first is the association
of age with risk status in our patients. Age is strongly associated with CVD, but there may
be other independent effects of age on WMH we aren’t able to discern in our analysis.
Better selection of subjects and larger recruitment would have helped overcome this
limitation. Another caution is the relatively low proportion of patients with high grades of
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WMH. We were able to offset this problem by normalizing distributions of WMH and
using non-parametric correlations for CBF, still achieving significant results, but these
findings should be confirmed in future studies. Additional methodologic analysis
considerations include our planned use of a 3D ASL acquisition for better comparison with
3D WMH volumes.
2.5

Conclusions
We find evidence that WMH are usefully divided into dWMH and pWMH regions

because they demonstrate differential associations with CVD and demographic risk
factors. 3D WMH volume is a potentially valuable marker for CVD that is able to
differentiate associations of pWMH and dWMH with risk factor profiles as well as cortical
and white matter CBF. Further studies using such methods in distinct and larger cohorts
are needed to conform and extend the present findings.
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POST-ACQUISITION PROCESSING CONFOUNDS IN BRAIN
VOLUMETRIC QUANTIFICATION OF WHITE MATTER HYPERINTENSITIES
3.1

Introduction
Neuroimaging is a critical tool for diagnosing neurodegenerative disease states

[15], such as vascular dementia and Alzheimer’s disease. The wide-spread availability,
high spatial resolution, and variety of imaging-sequences afforded by magnetic resonance
imaging (MRI) make it the ideal imaging modality for evaluation of cerebrovascular
contributions to cognitive decline. Significant effort has gone into standardizing
acquisition sequences for multi-site studies such as the Alzheimer’s disease neuroimaging
initiative (ADNI) [71], and the adoption of such consensus acquisition sequences beyond
ADNI has allowed a greater degree of cross-study comparisons than afforded previously.
Despite such standardization in acquisition protocols, post-acquisition processing
techniques for subcortical white matter hyperintensity volume quantification (WMH-VQ)
remain variable across studies and research sites. Few studies have examined the reliability
and reproducibility of volumetric MRI post-acquisition processing methods [72]. The few
studies addressing post-acquisition variability in MRI have focused exclusively on
structural segmentation methods. Schnack et al. performed a multi-center MRI study
focused on structural segmentation, where the image processing was performed at a single
site to reduce anticipated variability [73]. The study suggested that adding a thresholding
calibration to the processing algorithm might allow more uniform segmentation across
sites. However, this study did not assign multiple raters to verify their protocol, nor did
they validate the contention that a protocol, including a standardized thresholding
calibration, would reduce cross-site or inter-rater variability.
22
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Ramirez et.al. further addressed volumetric protocol reliability using three raters
and two repeat scans (interval ~30 min – 50 days) for twenty subjects [74]. However, the
study did not examine variability between raters, although they did comment on the issue
of variance in the output volumes, which they proposed to be related to brain structure
changes during the long interval between the repeated scans, rather than inherent variability
in the post-acquisition processing directly. No such studies have as of yet focused on
assessing the inter-rater reliability of WMH-VQ techniques.
Visual rating scales have been developed for assessing WMH burden, and while
these are reasonable choices for clinical evaluation given their ease of use in facilities
lacking modern post-acquisition image processing facilities, they are limited by floor and
ceiling effects and do not allow precise quantification necessary for detecting subtle
changes in imaging characteristics over time [75]. For this reason, semi-automated and
automated techniques have been developed as more reliable and sensitive measures for
WMH-VQ [76]. Despite the inherent benefits of automated post-acquisition WMH-VQ
techniques, the mean values of WMH volume derived from distinct studies often
demonstrate significant variability with mean volumes ranging from 0.5 – 11.2 cc3 (~5%
of the average WMH-VQ across subjects), across otherwise comparable cohorts [77-84].
While such differences are frequently assumed to be due to differential cohort
characteristics, it is also possible that inherent sources-of-variability in post-acquisition
image processing techniques are responsible for such error given the large number of
competing protocols in widespread use [77].
Despite advances in the field of quantitative neuroimaging, no universally agreed
upon or standardized methodologies for WMH-VQ post-acquisition processing exist today,
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nor have the potential sources-of-variability in such protocols been systematically
identified and addressed. In general, protocols for WMH-VQ use the same basic concepts
regardless of differences in processing tools (software and algorithms), type of algorithm
(semi or fully automated), or study design (cross-sectional or longitudinal) including: 1)
image registration, 2) nonbrain tissue stripping, 3) intensity estimation and thresholding,
and 4) manual editing (as deemed necessary), yet such differences may influence
variability in WMH-VQ. As such, an understanding of the sources-of-variability inherent
in WMH-VQ is critical for comparisons of findings across centers and for the integrity of
multi-site studies that do not utilize a centralized processing site or standardized, validated,
multi-site post-acquisition processing protocol. Furthermore, such understanding of
WMH-VQ variability is essential for interpretation of longitudinal studies examining
within-subject change, as the potential variability inherent in different quantification
protocols (due to advances in software or other scientific/technologic factors), whether
semi- or fully automated, can exceed the annual rate of change in WMH volumes for any
given subject. The present study systematically analyzed potential sources-of-variability in
WMH-VQ procedures that may potentially confound cross-center comparisons, limit the
reliability of multi-center studies, and further preclude an accurate understanding of
longitudinal within-subject WMH-VQ change.
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3.2
3.2.1

Materials and Methods
Participants
MRI acquisitions for 71 subjects (65 – 85 years old, spanning the cognitive

continuum from normal through mild cognitive impairment (MCI) to dementia) from the
Sanders-Brown Center on Aging (University of Kentucky) research cohort were collected
using a standard protocol. A random sample of scans from 21 participants was used for the
discovery phase of the study with the remaining 50 participant scans used for validation.
Details of the clinical characterization of this cohort have been published previously [85].
This study was approved by the University of Kentucky Institutional Review Board under
the protocols used to acquire the clinical data and MRI images.
3.2.2

MRI Acquisition
All MRI scans were acquired at the University of Kentucky, MRISC using a

Siemens 3T TIM-Trio MRI scanner (Siemens Healthcare, Erlangen, Germany). A 32channel head coil was used to scan the subjects. Two acquisition sequences were executed
for this study: 1) 3D MPRAGE, TE 2.3 milliseconds, TR 2,530 milliseconds, IR 1,100
milliseconds, FA 7°, 1×1×1 mm resolution full-brain coverage; 2) FLAIR image, TE 388
milliseconds, TR 6,000 milliseconds, IR 2,200 milliseconds, 3D 1×1×1 mm. No gap
between slices. All studies presented used identical imaging acquisition protocols, along
with the same scanner and head coil.
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3.2.3

Image Processing
MRI images were processed using an automated WMH-VQ method, described

previously [20]. Briefly, all MRI images were normalized for intensity. Two MPRAGE
images were acquired and co-registered using statistical parametric map software (SPM8
or SPM12) (http://www.fil.ion.ucl.ac.uk/spm) and averaged. The averaged-MPRAGE
were then registered to the single 3D FLAIR image. Nonbrain tissue was stripped from the
registered averaged-MPRAGE image using a brain extraction tool (FSL-BET), FSLFMRIB software

library

(FSL v5.0.9)

(http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/BET).

Remaining scalp tissue was removed slice-by-slice manually, as needed, using the medical
image

processing

analysis

and

visualization

(MIPAV

v7.4.0)

application

(http://mipav.cit.nih.gov). FLAIR images were generated from the binary mask of the
stripped averaged-MPRAGE and were further segmented using the SPM unified regime.
Five segmented images including, GM, two WM subsegments, CSF, and the unclassified
tissue masks were created in a native-space using an in-house segmentation template
created from 145 images of healthy normal adult subjects, demographically similar to the
subjects in this study [86]. The two WM masks were generated for different WM classes
that cannot be captured by one mask (tissue class) and were further summed to create a
binary WM mask that was multiplied by the FLAIR. This step isolates all of the classified
white matter voxels in the FLAIR image. The intensity distribution of these voxels was
then fit with a Gaussian curve. The maximum and minimum threshold values were
computed from the Gaussian distribution mean and standard deviation. The threshold value
was then applied to the stripped FLAIR images to obtain the final WMH-VQ mask.
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3.2.4

Study Design
MRI images were used for both discovery and validation arms of the project as

follows: twenty-one scans were used for analyzing the variability associated with software
and system compatibility, choice of the center of gravity (CoG), threshold calculations, and
manual editing procedures as part of the discovery dataset (Fig. 3-1). An independent
sample of 50 MRI images was used to analyze the validation dataset after controlling for
sources-of-variability identified in the discovery phase of the study.

Figure 3-1: Flow chart summarizing the use of the discovery dataset.
A total of 21 scans were examined for discovering the distinct sources-of-variability
inherent in white matter hyperintensity volumetric quantification (WMH-VQ)
processing techniques.
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3.2.5

Software Compatibility
The computers for this study are Linux operating systems and have the same

software versions, MATLAB a2015b (MathWorks, Inc), MIPAV v7.4.0, and FSL 5.0.9.
Two versions of SPM, including SPM8 and SPM12, were used to examine variance
inherent in specific software versions. For this experimental aim, we did not vary other
software programs and so recognize that our findings may not generalize across all
software systems and version discrepancies. Variability was assessed by comparing the
WMH-VQ measurements from identical scans using both SPM8 and SPM12-based
analyses.
3.2.6

Center of Gravity
The center of gravity (CoG) is linked to the nonbrain extracting process [87]. An

accurate CoG enables a smooth stripping process with virtually no additional manual
editing required. To allow assessment of potential variance that is associated with a
differential selection of the CoG, two random CoGs were selected for each subject in
addition to the systematic CoG. The systematic CoG was chosen by displaying; the
registered averaged T1-weighted image using the Triplaner display module in MIPAV to
locate the CoG visually (C1), using the cursor (estimating the brain center as one half the
brain anterior-posterior, left-right, and inferior-superior distances). The second CoG (C2)
was selected using the default CoG of the Triplaner display. The third CoG (C3) was
randomly chosen manually by the post-acquisition analyst, but its location was restricted
to within a 0.5 cm diameter of C1. Variability was assessed by comparing the WMH-VQ
measurements from identical scans using C1, C2, and C3 as the independent variables.
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3.2.7

Threshold Calculation and WMH Volume Quantification
To extract the WMH volume, the WMH distribution must be defined [88, 89].

Variability in WMH-VQ are exacerbated when the minimum WMH intensity distribution
overlaps with the normal appearing WM intensity distribution, leading to either to over- or
under-estimating WMH-VQ due to inconsistent thresholding. We used 10% of the
maximum FLAIR WM voxel intensity as the minimum value to obtain the histogram
distribution of the WM tissue. This lower limit is flexible and does not appear to contribute
significant error in the fitting procedure. However, the upper threshold value is a critical
factor for quantifying WMH volume. A two-Gaussian curve fit to the distribution
(MATLAB curve-fitting tool) was used for computing the mean and standard deviation
(SD). The mean and SD were applied to the thresholding equations to calculate the
maximum and minimum thresholds. The thresholds were 𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 + 3 𝑥𝑥 𝑆𝑆𝑆𝑆 for the lower

bound and 𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 + 15 𝑥𝑥 𝑆𝑆𝑆𝑆 for the upper bound [20]. The upper bound eliminated
extreme values occasionally seen as intensity artifacts in FLAIR images. All threshold

values were expressed to the second decimal place. WMH mask artifacts were reduced
using a Gaussian filter (1 x 1 x 1 mm). Total WMH volume was calculated from the final
WMH mask.
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We tested two parameters in our experiment to study their influence on the
thresholding values and in turn on the WMH-VQ. First, we compared the mean and SD of
the histogram distribution of the WM voxels extracted from the FLAIR image using voxel
intensity and position on the Gaussian curve, versus voxels intensity and volume in mm3
rather than position on the Gaussian curve. Second, we tested the impact of the precision
of the mean and standard deviation on the calculation of the thresholding values. We choose
the mean and the SD using the systematic algorithm described above carried to two
significant digits (decimal places) as increasing the precision beyond this (i.e., adding
additional significant digits (decimal places) did not further contribute to accuracy in the
resultant WMH-VQ derived. This threshold was then compared to setting the same mean
and SD threshold at a single or no significant digits (an integer).
3.2.8

Manual Editing
The sources-of-variability assessed above are all operator independent, but do not

consider artifact removal, which can be an additional source-of-variability that may require
one or more manual editing steps. In order to define the variability associated with manual
editing, two manual editing steps were included in the protocol to ensure that artifact did
not confound the conclusions drawn regarding post-acquisition processing variability.
Manual editing was performed on: 1) the whole brain mask after the nonbrain tissue
extraction process and 2) the final WMH mask.
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Manual editing was performed independently without standardization of
procedures and again after developing a standard editing protocol to minimize operatordependent error in these steps as follows. Extraneous voxels of T2 hyperintensity that are
generated due to pulsation and flow artifacts were removed manually, guided by the
original FLAIR image. A FLAIR image was displayed with a standard Gaussian-fit mean
center and 𝑡𝑡𝑡𝑡𝑡𝑡 𝑥𝑥 𝑆𝑆𝑆𝑆 grey scale window value side-by-side with the WMH mask, and the

second image was kept with its original values, to allow maximal recognition of false
positive and negative voxels. Fig. 3-2 demonstrates the spectrum of false hyperintensity
signals that were removed from the GM, lateral sulcus and pineal gland, the voxels between

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Figure 3-2: Common hyperintensity signal artifacts in the white matter hyperintensity
(WMH) mask.
The possible artifacts include: Grey matter signals (GM), (a), and (b), (arrowhead); Lateral
sulcus and pineal gland, (a), and (b), (rectangle); Voxels in between and inside the
ventricles, a, b, c, and d, (narrow arrow); Voxels in cerebellum (e) and (f) (circle); Voxels
in the pons and lower slices (g) and (h) (large arrow).
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and inside the ventricles, voxels in the cerebellum, and the voxels in the pons and lower
brainstem. A synopsis of our manual protocol guidelines is presented in Table 3-1.
Table 3-1. Manual editing protocol developed to systematically reduce sources of variation
in the assessment of subcortical small vessel ischemic disease. Sources-of-variability and
areas of analysis that require increased diligence and further development of standardized
methodology are identified.
Areas to systematically
review for T2 artifact

Rationale

Illustrations in
Fig. 3-2

Common extraneous
voxels

False intensities identified compared a and b
to original FLAIR image

Cortical GM

Extends beyond anatomic boundaries a and b,
of subcortical disease, but may be (arrowhead)
considered important for some
studies

Lateral sulcus/insular
cortex and pineal gland

Signal artifact due to CSF boundary

a and b,
(rectangle)

Areas of contrast with GM Artifact due to CSF boundary and a, b, c, and d,
and CSF between and
pulsation
(narrow arrow)
inside the ventricles
Cerebellum

Prone to infra-tentorial artifact and e and f (circle)
extensive CSF boundaries, but may
be considered important for some
studies

Pons and lower slices

CSF pulsation from forth vertical g and h (large
may produce hyperintensity voxels in arrow)
the pons. The extensive artifact in
lower slices due to bone & CSF
boundaries

Pituitary gland &
cavernous sinus

Extensive artifact due to bone & CSF g and h (large
boundaries
arrow)

Basal ganglia & thalamus

Deep GM artifacts due to Not shown
homogeneous T2 signal need to be
distinguished from true small vessel
ischemic disease
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Variability due to manual editing was assessed by comparing the WMH-VQ
measurements from identically processed scans using both unstandardized and
standardized manual editing protocols as the independent variables.
3.2.9

Validation of a Standard Protocol to Reduce Variance
Controlling for selection of CoG, WM segmentation in SPM, curve fitting and

threshold setting on the WM histogram, and manual editing produced a final protocol that
was validated in an independent set of 50 MRI scans. We set the threshold for success at
0.5% variability as an acceptable limit of variability well within the range of anticipated
within-subject annual longitudinal change. The current variability for WMH-VQ was
calculated as a mean of the variability assessed across all parameters studied at ~15%,
based on the assumptions that inter-study, and intra-site inter-rater reliability would
represent an average rather than cumulative (additive) effect on WMH-VQ assessments.
3.2.10 Statistical Analysis
Using the 21 discovery images, WMH volumes were calculated in a four-step
process as follows. First, two raters assessed WMH volume under the protocol described
in Section 2.3 above, one using SPM8 (OA) and one using SPM12 (AB). Variability in
ratings was measured by the percent difference in the two raters’ ratings, as given below.
Next, the software package was fixed (SPM12), and one of the two raters (AB) calculated
WMH volume based on different CoG (as described in Section 2.6). Then, both software
and CoG were fixed, and the rater (AB) calculated WMH volumes under different
thresholding conditions, as described in Section 2.7. The distribution of the WM voxel
intensity and position on the curve was visualized using histograms.
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Finally, software, CoG, and threshold were fixed, and manual editing was applied
by both raters. The percentage difference (PD) for each set of ratings for each image, which
was defined as the difference between the two sets of measurements divided by the average
value of the two methods, for each source of variability (i.e., software compatibility, CoG,
thresholding, and manual editing):
Percentage Difference (PD) = |

𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 1 − 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 2
| 𝑥𝑥 100
𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 1 + 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 2
2

These summary PDs were used to quantify the approximate measurement error
associated with each source of variability. The overall PD for each discovery image was
calculated by taking the average of the four individual PDs. The WMH volumes obtained
after implementing all four steps are referred to hereafter as “standardized” WMH.
Once the analyses based on the discovery data were completed, the two raters each
calculated WMH volume for the set of 50 validation images based on the unstandardized
and standardized protocols. Interrater agreement was assessed using the Pearson
correlation coefficient and the Interrater Reliability. SigmaPlot 13 (Systat Software Inc.,
San Jose, California) was used for statistical data analysis.
Additionally, the permutation test (aka randomization test; MATLAB function
https://www.mathworks.com/matlabcentral/fileexchange/63276-permutation-test)

was

applied to the 50 standardized WMH volumes to test whether mean WMH volume was
different between raters (50,000 permutations). Finally, the Dice similarity test (using
MATLAB) was utilized to find the similarity and dissimilarity of the WMH final masks
before and after the manual editing between the two raters.
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3.3
3.3.1

Results
Participants
The mean age of this cohort was (74.1 ± 8.0) years, the mean educational attainment

was (16.9 ±3.3) years, and the mean WMH volume was (14.5 ± 23.0 cc3). In addition, 54%
were female, 66% were hypertensive, 26% were diabetic, 10 were smokers, and 56% had
hyperlipidemia. Finally, 30% of the cohort were cognitively normal, and the remaining
70% had the diagnosis of mild cognitive impairment at the time of the scan. There were no
significant demographic or clinical differences between the discovery and validation data
set participants in this study.
3.3.2

Software Versions and Compatibility
Different SPM software versions and software compatibility were found to be a

significant source-of-variability. Analysis using SPM8 resulted in an overestimated WMHVQ compared to analyses using SPM12, 36.44% before editing and 93.26% after editing
(n = 21). Fig. 3-3 shows the difference between the two processed WMH masks in contrast
to the FLAIR image (Fig. 3-3a). Fig. 3-3b is the WMH mask resulting from the use of
(a)

(b)

(c)

Figure 3-3: WMH masks differ based on SPM versions used.
(a) is the original T2 FLAIR image. (b) WMH mask using MATLAB 2015 and SPM8.
It shows an overestimate volume comparing to the FLAIR image and (c), which is the
WMH mask that quantified using MATLAB 2015 and SPM12.
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SPM8, while Fig. 3-3c is the mask utilizing SPM12. These data demonstrate the
importance of software version (even from the same source) in affecting variability in
WMH-VQ.
3.3.3

Selection of Center
The use of different CoGs introduced a variability of approximately 11% in final

WMH volumes. The percentage error in WMH-VQ (mean ± standard error of the mean
(SE) in mm3) determined using C2, (28360 ± 7460), and C3, (33235 ± 8036), compared to
C1, (33755 ± 7907), were 20.9% and 16.1%, respectively (n = 21). Fig. 3-4 demonstrates
the artifacts leading to increased WMH-VQ variability as a result of the choice of CoG.

(a)

(b)

(c)

(d)

Figure 3-4: The effect of the center of gravity (CoG) on bone extraction method using
BET-FSL tools.
(a) demonstrates optimal bone extraction with almost clean brain tissue. (b) and (c) show
non-brain tissue remaining (narrow arrows) due to choosing an alternate CoG. (d)
demonstrates a loss of a portion of GM due to the non-tissue extraction process as a result
of choosing an alternate CoG.

3.3.4

Thresholding
Fitting the histogram distribution of the WM intensities to the Gaussian curve was

also shown to contribute to interrater reliability variance in WMH volume before and after
manual editing. The percentage variance of fitting the WM histogram distribution of the

36

WM voxel intensities and volume, mean ± SE (39427 ± 8299), versus the WM voxel
intensities and position, (39759 ± 8237) on the Gaussian curve was found to be 2.5% (n =
21). Thresholding the FLAIR mask to compute the WMH volume was also shown to be a
significant source-of-variability. The percentage error between the thresholding values
carried to either none or one significant digit, versus the maximal selection of two
significant digits, was -19.9% and 10.2%, respectively. This percentage error is maximally
evident whenever the distribution is not corrected for the natural left-handed skew
deviation inherent in community-based samples such as ours and the many others that have
been studied to date.
3.3.5

Manual Editing
All steps in the WMH-VQ protocol represent automated processes that can be

standardized to reduce variability. While the protocol is fully automated, artifacts can create
erroneous volume estimates, and so manual editing may be desired in order to remove
artifacts when present. Variability due to non-systematic manual editing was 1.7% (rater-I,
28503 ± 8683 and rater-II, 28394 ± 8667) compared to systematic manual editing. Using
this systematic manual editing protocol, the variability in WMH-VQ was reduced to 0.34%
overall.
3.3.6

Validation of a Standardized Protocol
In order to investigate whether controlling for these sources of variability could

result in a protocol with a minimal acceptable variability (defined as < 0.5% WMH-VQ)
could be developed, we studied the performance characteristic of standardized protocol
using identical acquisitions, with post-processing performed by independent raters using
independent workstations, Inter-rater analysis, using Spearman correlations and linear
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regression models for WMH masks before and after editing (Fig. 3-5), demonstrated r2
values = 0.999, with SE = 118.7 and 68.1 respectively, and p-value < 0.001 for the 50 scans
used in the validation study. WMH volume variance in the refined protocol was 0.23%
before manual editing (all processes automated) and this increased only slightly to 0.34%
after manual editing once all sources-of-variability were addressed in a systematic fashion.
The permutation test showed the observed mean difference in WMH volume before manual
editing was 12.37, and p-value = 0.998; the observed mean difference was 0.97 and p-value
= 0.999 after editing, which again shows a good concordance between the raters. As well,
the Dice similarity test confirmed that result with 0.99 (dissimilarity: 0.009) before editing
and 0.98 (dissimilarity: 0.018) after manual editing.

(a)

(b)

(c)

Figure 3-5: WMH rater inter-rater results.
Regression curve for WMH volumes after and before editing (a) and (b), respectively,
(n = 50)). (c), the mean value of WMH volume for both raters before and after editing
(n = 50). r2 = 0.999, Standard error estimation before editing 118.7 and after editing
68.1. (p-value < 0.001).

3.4

Discussion
This study demonstrates that even automated post-acquisition WMH-VQ

techniques have several inherent sources-of-variability that can lead to discrepant results
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between raters and centers using different post-acquisition protocols. The importance of
this finding should not be understated, as the data generated and the conclusions drawn
from different raters and centers, even when using standardized data acquisition and source
images such as those acquired in ADNI or other large multi-center collaboratives, can be
quite discrepant if post-acquisition protocols have not been refined and such sources-ofvariability addressed.
The present data further demonstrate that systematically identifying and addressing
potential sources-of-variability inherent in post-acquisition WMH-VQ techniques can
result in a dramatic reduction in intra-scan variability from ~15% to less than 0.5%.
Sources-of-variability identified in the present study, and methods to overcome these
confounds, include the selection of CoG, thresholding effects, software versions, and
manual editing procedures (as included in the protocol). Specific discussion focused on
each identified source-of-variability and methods developed to reduce such variability are
presented below.
The present data demonstrate the importance of software compatibility for any
longitudinal, multi-center study lacking: 1) a central uniform post-acquisition processing
center, 2) central processing centers that undergo software upgrades between acquisitions
and processing of images, or 3) for between-study comparisons using different postacquisition processing regimens. SPM is based on the use of MATLAB scripts. Updating
one of these software packages without updating the other produced significant variability
in intra-scan WMH-VQ. As software versions are constantly evolving, it is necessary to reevaluate potential sources-of-variability introduced with each new software version
employed both within and across sites. As such, one should also consider the issue of
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variability introduced when combining legacy data with recently acquired data if software
versions are upgraded (as they are likely to be) over time. While such upgrades are
important for enabling technological progress in WMH-VQ measurements, unless legacy
scan data is reprocessed with the same software, drawing conclusions regarding
longitudinal datasets from post-acquisition data derived from protocols using different
software versions may be problematic. The present data demonstrate that considerations of
increased variability in such samples could be at least partially responsible for changes in
longitudinal trajectories or analyses examining historical or birth cohort effects.
Another source of variability lies in the selection of the CoG, which can affect nonbrain tissue extraction. Nonbrain tissue extraction is essential for optimal brain
segmentation [90]. The BET stripping tool is a common brain extraction tool that is easy
to use and to script [91, 92]. In order to obtain an accurate non-tissue extraction result with
BET, the CoG should be consistently and uniformly assigned across protocols [93, 94]. The
closer the CoG is to the center of the brain (tissue to be analyzed), the less non-brain tissue
artifact will be seen (see Fig. 3-4). Random estimation of the CoG or variability in such
estimation that differs by protocol could increase the sources-of-variability due to the
inclusion of residual of nonbrain tissue. This problem may be solved by either performing
manual editing, increasing the number of BET iterations [95], or editing the CoG manually
to ensure uniformity. The selection of three distinct CoGs isolated as independent variables,
allowed us to examine the variability associated with such selection independent of other
procedures. While many automated protocols select identical CoGs, the exact CoG selected
often differs by protocol, and many protocols do not take into account differences in brain
center coordinates that may vary from subject to the subject due to subject positioning in
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the scanner. Certain CoG selections can increase artifacts related to excess inclusion of
nonbrain tissue. Standardized selection of CoG, necessary to develop uniform protocols
across disparate raters, centers, and studies will require the development of consensus bestpractices in the field of post-acquisition processing.
The selection of an appropriate threshold is critical for specifying the volume of
WMH to include in the mask. If the threshold is set too high, it will reduce the sensitivity
of WMH detection, while setting the threshold too low can increase the presence of WMH
artifacts that may necessitate the inclusion of burdensome manual editing processes. The
highest sensitivity to thresholding value effects exists for subjects with large WMH
volumes and is less important for those with low levels of such imaging findings. The
present analysis found that two independent Gaussian curves provided the most consistent
principal fit to the mean of the hyperintensity distribution. Even though the histogram
distribution of WM using intensity and voxel position vs. voxel volume showed a relatively
small variance < 3%, it still remained one of the sources-of-variability in excess of the
acceptable threshold set in our study aims.
Manual editing may be necessary for accurate WMH-VQ assessment, as the WMH
mask will likely contain at least some FLAIR artifact. The decision to include a manual
editing step(s) may be dependent on the protocol specifics that either limit or increase
artifact representation in the WMH-VQ assessment. The present data demonstrate that
WMH-VQ can be overestimated by as much as 42% using an automated process without
manual editing. While such overestimates due to artifact may exhibit regression to the mean
when analyzing large samples, they prohibit accurate assessments of the true WMH-VQ
and further prevent accurate analyses when working with smaller samples or when
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considering within-subject change in WMH-VQ. While machine learning techniques are
being developed to address editing procedures systematically, manual editing may still be
required for many studies depending on the sample size and the nature of the hypothesis
being tested. It is important also to note that machine learning techniques often require the
“ground truth” in the training set. Therefore, obtaining an accurate “ground truth” was the
main purpose of the present study. Given these considerations, manual editing remains a
common necessity for WMH-VQ protocols until improved automated machine learning
techniques are introduced into the field.
While introducing human bias with manual editing procedures, the present data
demonstrate that the development of standard rules for manual editing can significantly
reduce intra-scan variability in the final WMH masks and WMH-VQ results, despite such
procedures. Specific editing rules that proved useful for reducing inter-rater variability
included: 1) removal of T2 hyperintensity artifacts in CSF/GM junctions, especially those
involving the septum pellucidum; 2) removal of all T2 hyperintensities below the level of
the midbrain, including the cerebellum, as this area is highly prone to significant pulsation
and other artifacts; 3) removal of T2 signal hyperintensities in the cortical GM; and 4)
editing of the supratentorial deep GM structures (including the basal ganglia and thalamus)
that require special attention as these structures are in end-arterial zones that are both
subject to high levels of small vessel ischemic disease and are also prone to significant
artifact. [96, 97] Irrespective of the specific rules for manual editing standardization that
are applied to a given protocol, it is clear that specifying such procedures and standardizing
them across raters, sites, and studies would help reduce the variability in WMH-VQ seen
within and across disparate studies.
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While the present findings and method developed to focus on a cross-sectional
analysis, the reduction in sources-of-variability suggested in the present methods are
critically important for any studies assessing longitudinal change in WMH-VQ. As changes
in WMH-VQ are estimated at ~5%/year, any protocol that introduces a greater degree of
variability in cross-sectional findings is likely to generate inaccurate longitudinal results.
Our analyses of both the findings reported in the literature and those described within our
study suggest that current variability demonstrated in WMH-VQ assessment is 10-15%, a
simply unacceptable figure. As study protocols and software versions are constantly being
modified for improvement overtime, re-grounding legacy data and longitudinal data
collection based on the principles described are critical for scientific discovery in the field
of WMH-VQ.
This new method of addressing post-acquisition sources-of-variability overcomes
this limitation and may further prove to be even more useful if integrated with other
acquisition methods to reduce variability, e.g., longitudinal data is acquired with the same
imaging sequence and protocol on the same scanner.
Study limitations include our focus on a largely Caucasian, highly educated, aged,
study population that may limit the generalizability of our findings to such populations.
Minority and underserved health-disparity populations at even greater risk for
cerebrovascular disease and WMH accumulation are an important focus of future studies
that we did not address directly in this study. In addition, caution should be used in
interpreting these data in regards to disease processes that may affect younger populations
such as those with multiple sclerosis, as such subjects were not studied in our experimental
design. Further limitations include the use of specific software programs that were analyzed
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and a statistical threshold-based analysis approach, and it is possible that the present
considerations studied may not be applicable to all software programs and version
upgrades. In addition, we did not fully explore how the region of interest (ROI) analyses
would be impacted by the use of standardized methodologies, although it is assumed that
such analyses would benefit from the standardized approach presented. Further work in
this area is clearly indicated. Despite such caveats, the present data suggest that careful
attention to what may seem to be simple changes in software version (incidental upgrades)
or selection of post-acquisition analysis parameters (selection of CoG and thresholding
limits), and standardization of operator-dependent steps (manual editing) may improve
cross-site, cross-study and longitudinal WMH-VQ assessments in order to advance the
field.
Future directions include analyzing the potential sources-of-variability in WMHVQ across-sites to identify better which variables are most important for establishing crosscenter reliability. A further focus on sources-of-variability that exist within subjects in
longitudinal studies also need to be pursued before we can possibly use within-subject
change in WMH-VQ as a reliable outcome measure for imaging findings related to vascular
cognitive impairment or vascular dementia. Data from the present study are also being used
currently as the “ground truth” in our collaborative development in advance artificial
intelligence machine learning approaches to WMH-VQ.
The final validation study attempted to determine if addressing all the sources-ofvariability identified in the study in composite would lead to a protocol with overall
reduced WMH-VQ variability that we considered acceptable (defined as variability <
0.5%). This was important as the field is in need of protocol development adequate to study
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within subject WMH-VQ change accurately in the setting of an average WMH-VQ change
that is approximately 5% of the total WMH-VQ measurement. This goal was achieved, on
the basis of the present set of experiments, demonstrating a post-acquisition WMH-VQ
variance well under our target of < 0.5%. While the standardized protocol used in this study
may not be ideal for many researchers, dependent on their needs and practical
implementation of the data derived, the lessons learned in addressing potential sources-ofvariability in WMH-VQ assessment techniques can be applied universally to help limit the
methodologic variability that confounds the present literature.
3.5

Conclusions
The present study sought to systematically identify sources-of-variability in WMH-

VQ techniques that can confound both within-site as well as cross-site data comparisons
and conclusions. This exercise allowed the development of a standardized protocol,
minimizing potential sources of bias and variability in the determination of WMH-VQ
measurements in our study sample. While the developed protocol was found to be optimal
for use in the present dataset for the detection of subcortical white matter disease, many
other protocols exist in the field and may have unique attributes that make them optimal
for their specific study purposes. Such protocols should, in light of the present data,
systematically evaluate the sources-of-variability inherent in their methodologies to move
the field of post-acquisition processing of WMH-VQ into a more rigorous and standardized
arena where data may be able to be better compared across studies and sites. In addition,
data on WMH-VQ that may represent a more reliable “ground truth” is critical for the
development and training of machine learning algorithms that may allow future artificial
intelligence approaches to WMH-VQ assessment.
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These data strongly support the notion that consensus “best-practices” should be
developed in the field to aid such discovery. Only through such initiatives can we hope to
advance our understanding of the risks, diagnosis, study outcome measures, and treatment
modality considerations that might mitigate the impact of small vessel ischemic disease on
the population today and in our future scientific endeavors.
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DIFFUSE OPTICAL ASSESSMENT OF CEREBRAL
AUTOREGULATION IN OLDER ADULTS STRATIFIED BY
CEREBROVASCULAR RISK
4.1

Introduction
Cerebrovascular disease (CVD) is the fifth most common cause of mortality in the

United States (0.14 million in 2017) [2, 3], and the second worldwide (17.6 million in
2016) [4]. Risk factors for CVD include aging, atherosclerosis, smoking, hypertension,
high cholesterol, and diabetes [5, 6, 8, 98]. Among others, aging represents the major risk
factor for the development of CSVD. Diagnosis of CSVD at early stages is essential for
preventing sequential complications. Ideal diagnostic tests should be noninvasive, lowcost, and have high diagnostic accuracy for CSVD in early stages of the disease.
CSVD is often associated with abnormal microvasculature and tissue dysfunction
in the brain, which may impact cerebral autoregulation (CA) [99, 100]. CA is a
physiological mechanism maintaining stable cerebral blood flow (CBF) within a certain
range of blood pressure variations [100, 101] . CA has been assessed by quantifying the
relationships (gains) of spontaneous low-frequency oscillations (LFOs) between the mean
arterial pressure (MAP) and cerebral hemodynamic parameters such as CBF and cerebral
blood oxygenation [102]. In general, smaller LFO gains correspond to better CAs [103,
104]. Although the origin of LFOs remains controversial in the literature, studies have
found that the endothelial, neurogenic, and myogenic controls are the main mechanisms
responsible for maintaining CBF constant during blood pressure fluctuations [105].
Previous studies have classified LFOs into four frequency intervals: I (0.005-0.0095 Hz),
II (0.0095-0.02 Hz), III (0.02-0.07 Hz), and IV (0.07-0.2 Hz) [106-112]. Interval-I and
Interval-II reflect respectively nitric oxide dependent and independent endothelial
Submitted for publication: Bahrani et.al (2020)

metabolic activities [107, 109, 110]. Interval-III and Interval-IV correspond respectively
to neurogenic and myogenic related metabolic activities [106, 111, 112].
In study of LFOs, MAP is often monitored by a noninvasive finger
plethysmography technique, which was used in this study. Functional MRI has been used
to image cerebral hemodynamics with high spatial resolution, although the high cost, low
sampling rate, and non-portability limits its frequent use. Transcranial Doppler ultrasound
(TCD) has been used to measure cerebral blood flow velocity (CBFV) in major arteries,
which may not be consistent with CBF in the microvasculature [23]. Also, TCD cannot be
performed in ~10% of subjects who do not have adequate acoustic windows [24]. Nearinfrared spectroscopy (NIRS) provides a noninvasive, rapid, portable, and low-cost
alternative for continuous monitoring of cerebral blood oxygenation in the
microvasculature, although it does not directly measure CBF [113]. Since CBF and
cerebral blood oxygenation are usually coupled and interactive, it is desirable to measure
both quantities and investigate their complex relationship.
TCD/NIRS has been used to measure LFOs in CBFV/cerebral blood oxygenation
for CA assessment [114-117]. Different orthostatic protocols were applied to induce MAP
fluctuations for evaluating dynamic CA including a sit-stand maneuver [118] and tilting
bed [114]. The selected LFO frequency intervals varied in different studies [109, 115, 117,
118], and study cohorts included age-matched older healthy subjects and patients with
symptomatic carotid occlusion, ischemic stroke, or Alzheimer’s disease (AD) [104, 116,
119, 120]. Previous studies have found that CAs (associated with LFO gains) were
impaired in patients with symptomatic carotid occlusion or ischemic stroke [104, 119, 120],
but preserved in patients with AD [116].
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Previously, we conducted a preliminary study in young healthy subjects using an
innovative

hybrid

near-infrared

spectroscopy/diffuse

correlation

spectroscopy

(NIRS/DCS) instrument to simultaneously quantify LFOs of CBF and cerebral blood
oxygenation at rest, during and after 70° head-up-tilting (HUT) [105]. The hybrid
instrument consists of a laboratory-made DCS device for CBF measurements and a
commercial frequency-domain NIRS device (Imagent, ISS) for cerebral blood oxygenation
measurements including oxy-hemoglobin and deoxy-hemoglobin concentrations ([HbO2]
and [Hb]). HUT was performed to enhance LFOs at ~0.1 Hz. Results from this pilot study
demonstrated the feasibility and reliability of using NIR diffuse optical technologies to
simultaneously quantify LFOs of multiple cerebral hemodynamic parameters including
CBF, [HbO2] and [Hb].
This study used the hybrid NIRS/DCS instrument to simultaneously detect LFOs
of cerebral hemodynamics in cognitively healthy older subjects with high or low-risk for
developing CVD. Cerebral hemodynamic data were continuously collected at rest, during,
and after 70° HUT. LFO intensities were extracted from the measured variables (MAP,
CBF, [HbO2], and [Hb]) using power spectral analyses in four frequency intervals
(Interval-I to Interval-IV) [106-112]. The LFO transfer function gains were quantified by
transfer function analyses with MAP as the input and cerebral hemodynamic variables
(CBF, [HbO2], and [Hb]) as the outputs [105]. Since LFO gains correlate inversely with
the CAs [103, 104], we hypothesized that they can be used as biomarkers for diagnosis of
CVD at early stages, i.e., distinguishing two groups of subjects with high or low-risk for
developing CVD.
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4.2
4.2.1

Materials and Methods
Participants
This study was approved by the University of Kentucky (UK) Institutional Review

Board (IRB). The written IRB consent was obtained from each subject before participation.
Twenty-six cognitively healthy older adults (23 females and 3 males) with a mean age of
77.7 ± 6.8 years (mean ± standard deviation) were recruited from a well-characterized
aging cohort, followed by the Alzheimer’s Disease Center (ADC) at the UK SandersBrown Center on Aging. Subjects with at least one of the following criteria were excluded
from the study: unstable cardiac diseases, orthostatic symptoms during upright standing,
non-CVD causes of cognitive decline, and AD risk factors such as APOE4 allele, atrial
fibrillation, and other coexisting brain disorders.
The level of individual’s risk for developing CVD was evaluated based on clinical
diagnosis by neurologists and ADC databases. The Framingham study risk scores were
adapted to predict CVD over 10 years including gender, age, history of diabetes, blood
pressure, smoking, and cholesterol level [20, 36]. The scoring scale of Framingham ranged
from 1 to 30 points. The 26 subjects with risks for CVD were classified into two groups
based on the cutoff of 15-points: low-risk group (n = 14) and high-risk group (n = 12).
4.2.2

Experimental Protocols
Following our established experimental protocol [105], the participant was asked

to lie in a supine-position on a tilting bed (Hausmann). Two Velcro strips were used (one
over the chest and another over the knee) to protect the subject from falling during HUT
(Fig. 4-1a). A hybrid NIRS/DCS probe (Fig. 4-1b) was fixed with a medical tap on the
middle of the forehead about 1-cm above the eyebrows to avoid frontal air sinuses. Another
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layer of elastic bandage was wrapped around the subject’s head to secure the probe and

Figure 4-1: A hybrid NIRS/DCS instrument for continuous and simultaneous
measurements of Δ[HbO2], Δ[Hb] and rCBF before, during and after head-up-tilting
(HUT).
(a) Illustration of a titling bed. and baseline, HUT, and recovery positions. (b) A hybrid
NIRS/DCS probe with multiple S-D separations. (c) A hybrid instrument integrating a
commercial NIRS device (Imagent, ISS) and a laboratory-made DCS device.
eliminate the influence of ambient light. The hybrid optical probe was connected to the
hybrid NIRS/DCS instrument for cerebral hemodynamic monitoring (Fig. 4-1c). A finger
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photoplethysmography sensor (Portapres, Netherlands), calibrated by a regular pressurecuff on the subject’s upper arm, was used to record MAP continuously. Optical data were
continuously recorded by the hybrid NIRS/DCS instrument throughout the entire
experimental protocol, which included a 10-min baseline at rest, 10-min HUT (70°), and
10-min recovery after HUT back to 0°. A physician stayed at the bedside of the testing
room for safety monitoring during experiments.
4.2.3

Hybrid NIRS/DCS Instrument for [HbO2], [Hb] and CBF Measurements
Details about our innovative hybrid NIRS/DCS instrument for simultaneous

measurements of [HbO2], [Hb] and CBF have been reported previously [105]. Briefly, a
commercial frequency-domain NIRS device (Imagent, ISS) was used for cerebral blood
oxygenation measurements. The Imagent device measured changes in amplitudes and
phases of frequency-modulated light (110 MHz) at two wavelengths (690 and 830 nm, <
10 mW) resulting from tissue absorption and scattering using four source-detector (S-D)
with separations of 2.0, 2.5, 3.0, and 3.5 cm. A simplified solution based on a semi-infinite
geometry for the photon diffusion equation revealed linear relationships between the
measured phases and logarithmic amplitudes versus S-D separations. The wavelengthdependent tissue absorption coefficient μa and reduced scattering coefficient μs′ were then
extracted by fitting the slopes of these linear relationships. The absolute baseline values of
[HbO2] and [Hb] were calculated from the measured μa at the two wavelengths. However,
due to the instability of phase slopes over time, phase data were ignored from our analysis.
The amplitudes at the two wavelengths from a single S-D separation (2.5 cm) were
eventually used to calculate the relative changes in cerebral blood oxygenation (i.e.,
Δ[HbO2] and Δ[Hb]) based on the Modified Beer-Lambert law [121, 122].
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A laboratory-made DCS device was used for CBF measurements [105, 123-125].
The DCS device used a long-coherence laser diode at 830 nm (100 mW, CrystaLaser) as
the source and 16 single-photon-counting avalanche photodiode detectors (APDs,
PerkinElmer) as the detectors with S-D separations of 1.5, 2.5, and 3.0 cm. The laser diode
transmitted long-coherent light through a source fiber (diameter = 200 μm) into the tissue.
The APDs detected temporal light intensity fluctuations in a single speckle area on the
tissue surface through single-mode fibers (core diameter = 5.6 µm), resulting primarily
from the motions of red blood cells in the microvasculature (i.e., CBF). Signals collected
by eight APDs at the S-D separation of 2.5 cm were averaged to improve the signal-tonoise ratio (SNR). The relative change in CBF (rCBF) was calculated by normalizing data
to its baseline value (assigned to be 100%) before HUT.
The laser diodes for DCS and Imagent measurements were turned on alternately to
avoid the light interference between the flow and oxygenation measurements. The
acquisition time for collecting one frame of cerebral hemodynamic data was ~1.4 seconds
(equivalent to a sampling rate fs = 0.7 Hz), which included ~0.8 seconds for Imagent
measurement, ~0.5 seconds for DCS measurement, and ~0.1 seconds for switching
between the two measurements.
4.2.4

Extraction of Low-Frequency Oscillation (LFO) Intensities/PSDs
LFO intensities of MAP, rCBF, Δ[HbO2] and Δ[Hb] under three physiological

conditions (i.e., at rest, during HUT, and during recovery after HUT) are extracted from
their power spectral densities (PSDs), calculated by Welch's method [105]. Briefly, 10-min
time course dataset under each physiological condition (~420 data points at the sampling
rate fs = ~0.7 Hz) is first detrended to remove the baseline shift. The detrended data are
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divided into eight segments with 50% overlap in two adjacent segments, producing a data
length of ~93 (420 × 2/9) points for each segment. The PSDx (f) and PSDy (f) are generated
by MATLAB function of “pwelch”. Here, x denotes to the MAP signal, y denotes to other
physiological signals (CBF, [HbO2], and [Hb]), and f is the frequency with a resolution of
~0.0075 Hz (fs/93) in the range of 0.005 to 0.2 Hz. The cross-spectral density CSDxy (f) is
calculated by MATLAB function of “cpsd”.
4.2.5

Assessment of LFO Gain and Cerebral Autoregulation (CA)
CA has been assumed to be a linear system with MAP as the input and cerebral

hemodynamic parameters as the outputs. The gain G(f) of a linear system is quantified by
transfer function analysis G(f) =

CSDxy (f)
PSDxx (f)

[105]. Here, G(f) is classified into 4 frequency

intervals: Interval-I = 0.005-0.095 Hz, Interval-II = 0.095-0.02 Hz, Interval-III = 0.02-0.07
Hz, and Interval-IV = 0.07-0.2 Hz. The mean value of G(f) in each frequency interval is
calculated as a biomarker to assess CA: CA ∝ 1⁄G(f) [103, 104].
4.2.6

Statistical Analysis

Independent t-tests are conducted to test intergroup differences in LFO gains
between the two groups at each frequency interval under each physiological condition
using IBM SPSS (SPSS, 2019). Wilcoxon signed ranks tests are performed to test the
intragroup differences between the baseline and other physiological conditions (i.e., during
and after HUT). A p-value of < 0.05 is considered significant.
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4.3
4.3.1

Results
Subjects Characteristics and Valid Measurements
Although 26 cognitively healthy older subjects (23 females and 3 males) were

measured, one female subject from the high-risk group was excluded from data analysis
due to failure of optical measurements. One male subject from the low-risk group was also
excluded due to the occurrence of syncope during HUT. In addition, one female subject
from the low-risk group had an abnormal MAP measurement during the recovery.
Accordingly, 13 female subjects (73.0 ± 4.3 years) were included in the low-risk group for
data analysis (13 at baseline, 13 during HUT, and 12 after HUT for recovery). Nine females
and two males (84.2 ± 4.0 years) were included in the high-risk group (n = 11). The
significant difference in age between the two groups (P < 0.001) had been considered in
Framingham risk scores.
4.3.2

Time-Course Cerebral Hemodynamic Response to Head-Up Tilting
Fig. 4-2 shows the time-course data taken from two subjects with high or low-risk

for CVD before, during, and after HUT. All measured parameters at the resting baseline
were relatively stable. As expected, rCBF decreased during HUT due to the decrease of
cardiac output and the increase of cerebrovascular resistance induced by the orthostatic
stress. The reduced rCBF affected oxygen delivery, thus led to variations in Δ[HbO2] and
Δ[Hb]. Most of subjects (22 out of 24) had a trend similarly to these two subjects. However,
two subjects in the low-risk group exhibited an increase in rCBF (data not shown). After
recovery, all measured physiological parameters tended to return to their baseline levels.
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Figure 4-2: Illustrative time-course responses of MAP (mmHg), rCBF (%), ∆[HbO2]
and ∆[Hb] (μM) in two subjects.
The hemodynamic parameters were measured continuously at resting baseline (10
minutes), during HUT (10 minutes) and after HUT for recovery (10 minutes). (a) A 68
years-old female subject with low-risk for developing CVD. (b) A 84 years-old female
subject with high-risk for developing CVD.
4.3.3

LFOs of MAP, rCBF, Δ[HbO2] and Δ[Hb]
Fig. 4-3 shows the PSD data calculated from the same two subjects with high or

low-risk for CVD (Fig. 4-2). For both subjects, PSDs of MAP, rCBF, Δ[HbO2] and Δ[Hb]
varied during HUT and recovered towards their baseline levels after HUT.
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Figure 4-3: LFO intensities of MAP, rCBF, ∆[HbO2] and ∆[Hb] in two subjects before,
during and after HUT.
(a) A 68 years-old female subject with low-risk for developing CVD. (b) A 84 years-old
female subject with high-risk for developing CVD.
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4.3.4

Intergroup and Intragroup Differences in LFO Gains
Fig. 4-4 shows the LFO gain values of different variables (MAP, rCBF, Δ[HbO2]

and Δ[Hb]) in four frequency intervals (Interval-I to Interval-IV) for two groups (high or
low-risk for CVD) under three physiological conditions (at rest, during, and after HUT).
Overall, all LFO gains in the high-risk group were lower than those in the low-risk
group, although only some intergroup gain difference reached significance (marked with *
and p-values in Fig. 4-4, independent t-test).
During HUT, intragroup gains at Interval-I and Interval-II varied (increased or
decreased) from their resting baselines. However, most of intragroup gains at Interval-III
and Interval-IV reduced, except that the gain of Δ[Hb] at Interval-III in the high-risk group
elevated slightly. Moreover, HUT-induced gain reductions in the high-risk group are
generally smaller than those in the low-risk group, although most of these intragroup gain
reductions did not reach significance, except the rCBF gain reduction at Interval-IV in the
high-risk group (marked with § in Fig. 4-4, Wilcoxon signed ranks test, p-value = 0.026).
During recovery, most of LFO gains did not completely recover to their baseline
levels, except those at Interval-IV. Interestingly, intragroup and intergroup gain variations
across all measured cerebral variables (i.e., rCBF, Δ[HbO2] and Δ[Hb]) at Interval-IV were
highly consistent. LFO gains decreased during HUT and recovered to their baselines after
HUT. Significant intergroup gain differences were observed at rest and during recovery.
Moreover, the HUT caused smaller intragroup gain reductions in the high-risk group
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compared to the low-risk group, which changed the intergroup gain differences from
significant at rest to insignificant during HUT.

Figure 4-4: LFO gains of MAP, rCBF, Δ[HbO2] and Δ[Hb] in 4 frequency intervals
(Interval-I to Interval-IV).
The presented LFO gains are for two groups (high or low risk for CVD) under 3
physiological conditions (at rest, during resting baseline, HUT, and recovery). * indicates
significant differences in intergroup gains (independent t-test). § refers to a significant
difference in the intragroup gain (p-value = 0.026, Wilcoxon signed ranks test).
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4.4
4.4.1

Discussion
Study Innovations
The goal of the present study is to test whether LFO gains of cerebral hemodynamic

variables, quantified by our innovative hybrid optical instrument, are useful biomarkers to
distinguish two groups of cognitively healthy older subjects with high or low-risk for
developing CVD. Upon comparison with literature [104, 109, 114-120], we believe this
study is innovative in that: (1) it used an innovative hybrid optical instrument to
simultaneously measure multiple cerebral hemodynamic parameters including rCBF,
Δ[HbO2] and Δ[Hb] in cerebral microvasculature. Multiple cerebral functional parameters
provided more comprehensive assessment of brain activities than a single parameter alone;
(2) it studied a unique population: cognitively healthy older subjects stratified by
cerebrovascular risk; and (3) it innovatively explored CAs (extracted from LFO gains of
cerebral hemodynamics) as new biomarkers for diagnosis of CVD at preclinical stage.
4.4.2

Interpretation of Intergroup and Intragroup Differences in LFO Gains/CAs
At the resting baseline before HUT, all LFO gains in the high-risk group were

relatively lower than those in the low-risk group (Fig. 4-4). Particularly, significant
intergroup gain differences were observed in all measured cerebral variables (rCBF,
Δ[HbO2] and Δ[Hb]) at Interval-IV and in rCBF at Interval-I. The relatively lower gains
observed in the high-risk group may attribute to enhanced steady-state cerebrovascular
reactivity, metabolic reserve, or oxygen diffusion [106, 118, 126, 127], which act as
compensatory mechanisms to maintain the CA. HUT generated MAP fluctuations to
challenge the CA. As a result, intragroup gains at Interval-I and Interval-II fluctuated
(increased or decreased) from their resting baselines. However, most of intragroup gains at
Interval-III and Interval-IV were reduced, suggesting potentially stronger dynamic CAs
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during HUT compared to rest. Moreover, HUT-induced gain reductions at Interval-III and
Interval-IV in the high-risk group are generally smaller than those in the low-risk group,
suggesting potentially weaker dynamic CAs during HUT in this high-risk group [23].
Interestingly at Interval-IV, HUT-induced intragroup and intergroup gain
variations were highly consistent across all measured cerebral variables (i.e., rCBF,
Δ[HbO2] and Δ[Hb]): LFO gains decreased from their baselines during HUT and recovered
to their baselines after HUT. Moreover, intergroup gain differences were significant at rest
and during recovery. However, all intergroup gain differences became insignificant during
HUT due to different degrees of intragroup gain reductions. These results confirmed
weaker dynamic CAs (corresponding to smaller gain reductions) during HUT in the highrisk group compared to the low-risk group.
We speculate from these results that cerebrovascular risk affects primarily
neurogenic and myogenic activities to regulate CA, as Interval-III and Interval-IV
correspond respectively to neurogenic and myogenic related metabolic activities [106, 111,
112]. This speculation is supported by other studies in aging populations where neurogenic
and myogenic activities at Interval-III and Interval-IV were the substantial regulatory
factors for the CA in contrast to endothelial activities at Interval-I and Interval-II [109,
115]. In addition, cerebrovascular risk seems affecting rCBF more than Δ[HbO2] and
Δ[Hb], as more intergroup and intragroup differences were observed in rCBF than other
two variables (Fig. 4-4).
One important finding from this study is that cerebrovascular risk alters steadystate and dynamic CAs differently in cognitively healthy older subjects. As a result, the
high-risk group has stronger CA at rest but weaker dynamic CA during HUT. Interestingly,
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previous studies have observed that CAs were impaired in patients with symptomatic
carotid occlusion or ischemic stroke [104, 119, 120], but preserved in patients with AD
[116]. Accordingly, one potential future application is to use the innovative
technologies/protocols established in this study to investigate the differences in CAs as
biomarkers to differentiate subjects under different conditions such as high-risk for CVD,
CVD (e.g., symptomatic carotid occlusion or ischemic stroke), AD, and CVD plus AD. It
is crucial to know whether the cognitive deficit is caused by AD or by related vascular
problem, so that clinicians can make effective treatment plan accordingly. Unlike AD, there
are treatments available for controlling vascular conditions.
4.4.3

Study Challenges and Limitations
One major limitation of this study is the small number of subjects, which affects

our statistical analyses and study power. With only two male subjects included in this
study, for example, it is impossible to test gender influence on our results. Moreover, the
methodology – simultaneously measure multiple cerebral hemodynamic parameters with
hybrid optical instrument during HUT to identify new biomarkers (LFO gains) for
diagnosis of CVD at preclinical stage, is very unique to compare with other results. In
addition, the sampling frequency of the hybrid NIRS/DCS instrument is relatively low (0.7
Hz), which limits the extraction of LFOs in other intervals with higher frequencies such as
respiration (0.15-0.5 Hz) and cardiac (0.5-2 Hz) activities [111, 128, 129]. While HUT
creates orthostatic stress to challenge the CA, it may also cause syncope, as observed from
one participant in this study.
To improve the sampling rate of optical measurements, we recently worked on a
fast DCS technique using a software correlator (instead of a conventional hardware
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correlator) [130] to create a frame of CBF measurement within only 0.05 seconds. We also
explored adding a 785 nm notch filter in front of the Imagent detector so that both DCS
and Imagent data were collected concurrently without light interference across the two
measurements. With these improvements, the sampling frequency of NIRS/DCS
measurements reached 10 Hz. In addition, we are currently exploring other noninvasive
stimuli (e.g., memory tests, CO2 inhalations) for challenging the CA to avoid syncope
during HUT. Ultimately, we expect to study more subjects with the improved instrument
and experimental protocols in the future to draw solid conclusions.
4.5

Conclusions
A novel hybrid NIRS/DCS instrument was successfully used to simultaneously

detect LFOs of MAP, CBF, [HbO2] and [Hb] in cognitively healthy older subjects with
high or low-risk for developing CVD. The intragroup and intergroup differences in LFO
gains were characterized to evaluate CA differences between the low-risk and high-risk
groups as CAs correlate inversely with LFO gains. At rest before HUT, LFO gains in the
high-risk group were relatively lower than those in the low-risk group. Particularly at
Interval-IV, intergroup gain differences reached significance for all measured cerebral
variables. The lower baseline gains in the high-risk group may attribute to compensatory
mechanisms to maintain stronger steady-state CAs. Moreover, HUT resulted in smaller
gain reductions at Interval-III and Interval-IV in the high-risk group compared to the lowrisk group.
Particularly at Interval-IV, intergroup gain differences for all measured cerebral
variables were significant at rest and after HUT, but insignificant during HUT due to
different degrees of intragroup gain reductions. These gain variations induced by HUT
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suggest weaker dynamic CAs (corresponding to smaller intragroup gain reductions) in the
high-risk group compared to the low-risk group. These results suggest that cerebrovascular
risk affects neurogenic and myogenic activities (Interval-III and Interval-IV) more than
endothelial activities (Interval-I and Interval-II). In addition, cerebrovascular risk affects
rCBF more than Δ[HbO2] and Δ[Hb]. Taken together, LFO gains are potentially valuable
biomarkers for early diagnosis of CVD based on associations with CAs.
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TECHNOLOGICAL IMPROVEMENTS IN THE NIRS/DCS SYSTEM
FOR THE STUDY OF CVD
5.1

Introduction
In the previous studies (Chapter 4), I presented simultaneous measurements of

multiple cerebral hemodynamic parameters with our innovative hybrid NIRS/DCS
instrument for the detection of CVD at the preclinical stage. One constrain of that study is
the low sampling rate (0.7 Hz), which limits the extraction of signals at the high-frequency
band such as respiration (~0.5 Hz) and cardiac (~1 Hz) activities [111, 128]. Moreover, the
hybrid fiber-optic probe was restricted to use in glabrate skin such as the forehead.
To improve the sampling rate, I adapted a software correlator in the DCS technique
[130] to replace the conventional hardware correlator. I also explored adding a 785 nm
notch filter in front of the Imagent detector so that both DCS and Imagent data were
collected concurrently without light interference across the two measurements. With these
improvements, the sampling frequency of NIRS/DCS measurements reached 10 Hz.
Moreover, I designed a new fiber-optic probe with long fiber tips, which can be placed
between hairs to collect DCS data from the occipital lobe region.
The new system and fiber-optic probes were tested on two healthy older subjects.
CBF and cerebral oxygenation data taken from the frontal lobe and CBF data taken from
the occipital lobe were collected continuously using the improved hybrid NIRS/DCS
instrument with new fiber-optic probes, at resting baseline and during CO2 alterations to
alter cerebral hemodynamics.
The power spectrum density (PSD) was calculated from the measured variables
(CBF, [HbO2], and [Hb]). With the fast sampling rate (up to 10 Hz), our hybrid NIRS/DCS
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instrument can detect respiratory (~0.5 Hz) and cardiac (~1 Hz) events. Also, I
demonstrated the feasibility of DCS measurements at the occipital lobe (hirsute areas).
5.2
5.2.1

Materials and Methods
Participants
Two case studies were presented in this chapter to highlight these technical

improvements of the hybrid NIRS/DCS system. This study was approved by the University
of Kentucky (UK) Institutional Review Board (IRB). The written IRB consent was
obtained from each subject before participation. Two cognitively healthy older adults (one
female: 77 years and one male: 70 years) were recruited from a well-characterized aging
cohort, followed by the Alzheimer’s Disease Center (ADC) at the UK Sanders-Brown
Center on Aging.
5.2.2

Experimental Protocols
The participant was asked to lie down on her/his left side for installing a DCS probe

on the right occipital lobe area. Moreover, a hybrid NIRS/DCS probe was placed on the
middle of the forehead (~1 cm) above the eyebrows to avoid frontal air sinuses. An elastic
bandage was used to wrap around the head for securing the probe on the head and
preventing ambient light influence (Fig. 5-1a and Fig. 5-1b). These probes were connected
to the improved hybrid NIRS/DCS instrument with the fast sampling rate.
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A 5%CO2 protocol was integrated into this study to induce changes in cerebral
hemodynamics relative to the baseline. The protocol consisted of a continuous recording
of cerebral hemodynamics for a 6-minute baseline, followed by 4 sets of 5%CO2

(a)

(b)

(c)

Figure 5-1: CO2 experimental setup. (a) Demonstration of the occipital lobe.
(b) Measurement setup. (c) CO2 and room air (RA) inhalation protocol, including the
baseline (6 minutes), each CO2 (50 seconds), each RA (70 seconds), and the recovery (3
minutes).
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sequentially with an interval of room air inhalation, and then a total of 3 minutes recovery
(Fig. 5-1c). The CO2 inhalation was done thorough a mouthpiece connected to an airbag
with a mixture gas of 5%CO2, 21%O2, and 74%N2. The alteration between inhaled room
air and 5%CO2 was controlled manually. A nose clip was used to ensure the inhalation and
expiration through the mouth only. A CO2 monitor (Philips NM3, Philips Healthcare) was
used to monitor CO2 end-expiration during the measurement period.
5.2.3

Fast DCS Software Correlator
DCS principle and instruments have been described in Chapter 4. Conventional

DCS uses an autocorrelator board (Correlator.com, NJ, USA) to calculate the normalized
light intensity temporal autocorrelation function (g2) (Fig. 5-2a) [123, 131-133]. From g2,
the electric field temporal autocorrelation function (g1) is derived via the Siegert relation.
The blood flow index (BFI) is then obtained by fitting the measured g2 to the calculated
one based on the correlation diffusion equation [123, 131-133].
More recently, a new method with the software correlator was reported to improve
the sampling rate of DCS up to 20 Hz [130]. Briefly, the intensity of speckle fluctuations
on the tissue surface was collected and input to the computer via a fast counter board (PCIe6612 with internal time-base 80 MHz, NI, USA). A shift-and-add analytical method
substituted the hardware correlator to compute g2 function. The g2 computation depended
only on a few delay timepoints (e.g., 40 points in the upper segment of g2 curve) instead of
the full dataset (> 250 points) with the hardware correlator, thus significantly reduced the
sampling time. Studies have verified that the upper segment of g2 curve carries sufficient
information for CBF measurements in biological tissues [130, 134, 135]. With this
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improvement, the sampling rate of our new DCS with software correlator reached up to 20
Hz.
I adapted and optimized the new software correlator method for my study. The
original design utilized two counter boards: one for 8 detection channels and another for
the sampling clock. In my design, I utilized one of the 8 channels on a counter board for
the sampling clock and the remaining 7 channels on the same board for 7 parallel detections
(Fig. 5-2b). Therefore, using two counter boards, the number of detection channels was
increased from 8 to 15. This allowed us to connect two fiber-optic probes to these channels
for simultaneous measurements of frontal and occipital lobes. I also modified the graphic
interface (LabVIEW) to control the DCS instrument for multiple channel measurements.

Figure 5-2: Schematic diagram for both conventional and improved DCS machines.
(a) a block diagram for the traditional DCS. (b) a block diagram for the enhanced DCS.
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5.2.4

Fast Hybrid NIRS/DCS Instrument with Parallel Detection
Previously, our hybrid NIRS/DCS collected data sequentially to avoid light

interference between the blood flow and oxygenation measurements. The synchronization
between NIRS and DCS devices was through transistor-transistor logic (TTL) triggers
(Fig. 5-3a), which resulted in a low sampling rate of 0.7 Hz. In this study, I changed the
synchronization from the sequential mode to parallel mode (Fig. 5-3b). To avoid
interference of DCS light at 785 nm on NIRS measurements at 690 and 830 nm, a 780 nm
notch filter (Edmund Optics Inc.) was added in front of the Imagent detector. Since Imagent
(a)

(b)

Figure 5-3: A schematic diagram for representing the synchronization modes of
NIRS/DCS.
(a) represents the traditional NIRS/DCS sequential synchronization. (b) represents the new
synchronization mode (Parallel Mode). The blue cylinder represents a notch filter (785 nm)
for blocking the DCS laser source wavelength.
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lights at 690 and 830 nm were relatively weak, their influences on DCS measurements
were ignorable. With the parallel detection, the sampling rate of hybrid NIRS/DCS
measurements reached 10 Hz.
5.2.5

Improved Hybrid NIRS/DCS Probe Design
Fig. 5-4 shows our previous (a) and improved (b) hybrid NIRS/DCS probes.

Adding a notch filter to the Imagent detector allowed the DCS source to be placed closer
to the Imagent detector, thus generating a better overlap area across the two measurements
(NIRS and DCS).

Figure 5-4: Hybrid NIRS/DCS probe design.
(a) Traditional NIRS/DCS probe. (b) Improved NIRS/DCS probe.
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5.2.6

Improved DCS Probe Design for Measurement of Occipital Lobe with Hairs
Most of the previous studies including ours with DCS used fiber-optic probes

placed on frontal heads without hairs (Fig. 5-4). DCS usually used a single-mode fiber with
a diameter of 5.6 μm to detect single speckle contrast on the tissue surface. Hairs could
easily block light detected by this single mode fiber [136, 137]. To overcome hair
influence, I designed a fiber-optic probe with long tips that can be used on the occipital
lobe with hairs (Fig. 5-5). The probe had many holes for changing the source-detector
separations. The design allowed optical fibers moving around on the occipital lobe to avoid
hair blockage. The fiber tip diameter was increased from 2.5 to 5 mm to reduce the pressure
of the fiber tip on the skin. Two Velcro taps were integrated into the probe for fixing the
probe on the head.
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Distance
fixer

(a)

Thickness
(b)

(c)

(d)

Figure 5-5: The new DCS probe for occipital lobe measurements.
(a) A schematic diagram of the probe design. (b) An overview of the probe. (c) Top
view of the probe shows the source and detector fibers. (d) Side view of the probe shows
the fibers sliding out the probe for a better visuality to place the fibers on a participant's
head between hairs.
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5.3

Results

5.3.1

Resting Baseline Autocorrelation Functions Measured by the Fast DCS
Fig. 5-6 shows the autocorrelation curves from two participants measured by our

fast DCS devices with the source-detector separation of 2.5 cm on frontal (Fig. 5-4) and
occipital (Fig. 5-5) lobes, respectively at a sampling rate of 3 Hz. Data were averaged
respectively from 6 detectors in the frontal lobe and 7 detectors in the occipital lobe.
Interestingly, autocorrelation curves collected from the occipital lobe in both two
participants are smoother than those from the frontal lobe. That was partially due to the
flexible occipital probe (Fig. 5-5), which allowed for a better fiber contact with the head.
In addition, light intensities detected at occipital lobes were generally stronger than those
at frontal lobes. These data demonstrated the feasibility of DCS measurements in the
occipital lobe with hairs.
(a)

(b)

Figure 5-6: The autocorrelation curves (g2) measured from two participants.
(a) Participant 1 (female, 77 years). (b) Participant 2 (male, 70 years).
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5.3.2

CBF Responses to CO2
Fig. 5-7 shows the time-course rCBF data measured by the fast DCS from frontal

and occipital lobes, respectively at a sampling rate of 3 Hz. Data were aligned based on
CO2 changes delivered to the participant. rCBF data were normalized to the 30-second
baseline right before CO2 inhalation.

(a)

(b)

Figure 5-7: Time-course rCBF responses to CO2 inhalations from two participants.
(a) Participant 1 (female, 77 years). (b) Participant 2 (male, 70 years). The data were
normalized to the first 30 second right before the first CO2 cycle.
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5.3.3

Cerebral Oxygenation Responses to CO2
Fig. 5-8 shows the time-course cerebral oxygenation changes (Δ[HbO2] and

Δ[Hb]) collected from the frontal heads of the two participants.
(a)

(b)

Figure 5-8: Time-course [HbO2] and [Hb] responses to CO2 inhalations from two
participants.
(a) Participant 1 (female, 77 years). (b) Participant 2 (male, 70 years).
5.3.4

Low-Frequency Oscillation Signals
Fig. 5-9 and Fig. 5-10 show the calculated power spectral density (PSD) of rCBF,

[HbO2] and [Hb] data, obtained from the two participants. The PSDs were computed at the
resting baseline, combined CO2 events, and combined room air events. The CO2 and room
air segments were combined respectively to get sufficient data for each event. The PSD
results of the rCBF data show the heart rate component (~1 Hz) more obvious than the
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oxygenation parameter due to the direct relationship between the blood flow and heart
beating. Moreover, increasing the sampling rate enhanced the detections of low frequency
oscillations, compared with our previous results (Fig. 4-3 in Chapter 4).

(a)

(c)

(b)

(d)

Figure 5-9: The power spectral density (PSD) data of rCBF extracted from the time course
data shown in Fig. 5-7.
(a) and (b): Participant 1 (female, 77 years). (c) and (d) Participant 2 (male, 70 years). (b)
and (d) are zoom-in view of (a) and (c), respectively to show LFOs.
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Figure 5-10: The power spectral density (PSD) data of [HbO2] and [Hb] extracted from
the time course data shown in Fig. 5-8.
(a) Participant 1 (female, 77 years). (b) Participant 2 (male, 70 years).
5.4
5.4.1

Discussions
Study Innovations
This chapter aims to improve the sampling rate of NIRS/DCS and investigate the

adaption of DCS for measurements in the occipital lobe with hairs. The study innovations
include: (1) adapting and optimizing an innovative software correlator to increase the
sampling rate and the number of detection channels; (2) using new parallel synchronization
for NIRS/DCS measurements to increase the sampling rate; (3) designing a new DCS probe
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to measure CBF at the occipital lobe with hairs; and (4) measuring simultaneously CBF
and cerebral oxygenation at both frontal and occipital lobes, for the first time.
5.4.2

Preliminary Result Interpretation
Our preliminary result from two participants demonstrate the improvement in the

sampling frequencies for both DCS (using a software correlator) and hybrid NIRS/DCS
(using the parallel detection). These improvements enable recording of a large range of
frequencies including respiratory and heart beating events. The improvement also
facilitates studying high-frequency component of the physiological activities along with
low-frequency oscillations (LFOs). Notably, increasing the number of channels (N) of DCS
with the fast software correlator also helps to improve the SNR by √𝑁𝑁 times via averaging

signals from multi-channels (N).

Another accomplishment enabled by using the multi-channel parallel detection and
new probe is the ability to collect CBF data from discrete areas (i.e., the frontal and
occipital lobes). The new occipital probe overcomes the restriction of DCS on glabrate
(non-hirsute) areas with a new probe design. This probe can be also upgraded to a hybrid
NIRS/DCS probe for simultaneous measurements of CBF and cerebral oxygenation at both
the frontal and occipital lobes. Measurements of multiple areas are important to understand
the origin and severity of neurodegenerative diseases. For example, cerebral amyloid
angiopathy (CAA) in the early stages starts at the posterior part of the brain and then spread
out to the front [138, 139].
The CO2 inhalation causes hypercapnia that induces cerebral vessel dilation as a
direct effect of the extracellular H+ on the vascular smooth muscle [140]. The time course
data show the interaction between rCBF and CO2 inhalation as a consequence of
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vasodilation effect. Generally, rCBF increased during CO2 inhalation and decreased during
room air. However, we noted that CO2 inhalation has an accumulative impact (especially
within a short alteration time, Fig. 5-1c) on CBF, resulting in continuous increase of CBF
for both cases (Fig. 5-7). By contrast, time course data of cerebral oxygenation in both
participants showed relatively smaller changes in response to CO2 inhalations. Previous
studies have found similar CBF and oxygenation variations during CO2 inhalations,
measured by fMRI [141-143] and by manometric technique [144].
LFOs around 0.1 Hz were observed in all measured cerebral hemodynamic
parameters (Fig. 5-9 and Fig. 5-10). Due to our high sampling rate (3 Hz), LFOs of rCBF
showed higher respiratory peaks at ~0.5 Hz and heart beating peaks at ~1 Hz (Fig. 5-9),
compared to oxygenation oscillations (Fig. 5-10). This is not surprising as blood flow
changes are directly related to blood pressure variations. In addition, LFOs of
hemodynamic parameters were different at different physiological conditions. LFOs of
rCBF decreased during CO2 inhalation (Fig. 5-9c and Fig. 5-9d) compared to the baseline
and room air inhalations, which are consistent with literature [145].
5.5

Conclusions
The improved NIRS/DCS technologies with parallel detection, high sampling rates,

and new probe design allow us, for the first time, to measure both CBF and cerebral
oxygenation at frontal and occipital lobes. In the future, more subjects will be studied with
the improved technologies to detect cerebral hemodynamic alterations in subjects with
cerebral diseases such as CSVD or at the risk for developing cerebral diseases.
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STUDY SUMMARY, LIMITATIONS AND FUTURE PERSPECTIVES
6.1

Study Summary
In this thesis work, I tested whether white matter hyperintensities (WMH) and

cerebral hemodynamics quantified by the MRI (Chapter 2) and a hybrid NIRS/DCS
instrument (Chapter 4) can be used as biomarkers to distinguish two groups of cognitive
healthy older subjects with high or low risk for developing CVD. I found that regional
WMH volumes based on associations with cortical and WM CBF values and LFO gains of
cerebral hemodynamics based on associations with CAs are potential biomarkers for early
detection of CVD.
The high spatial resolution, large penetration depth, and variety of imagingsequences afforded by MRI make it an appealing imaging modality for evaluation of
CSVD, although MRI requires expensive instrumentation and transfer of subjects from bed
to imaging facility. By contrast, low-cost, portable, mobile diffuse optical technologies
provide a compensatory alternative for early screening of CSVD and continuous
monitoring of disease progress at the subject’s bedside. In addition, I also developed a
standardized protocol for optimizing the post-acquisition processing methods in the MRI
to reduce the inter-rater variance (Chapter 3) and fast parallel detection technique in the
NIRS/DCS to improve the sampling rate (Chapter 5). Most of these results have been
published or submitted to peer-reviewed journals [20, 146, 147].
My major contributions of these studies are in following aspects. In Chapter 2, I
participated in the design of the cross-sectional volumetric method for quantifying regional
and global WMH and CBF using MRI techniques in cognitively healthy older subjects with
high or low risk for developing CVD. I developed methods to segment the WMH and CBF
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(ASL) into deep and periventricular regions. Moreover, I successfully registered CBF
images to the T1-weighted images for regional segmentations. I ran the full protocol to
analyze the data in the study cohort and found that WMHs at deep and periventricular
regions had differential associations with CVD and demographic risk factors. Thus, the
regional WMH volume is a potentially valuable biomarker for CVD.
In Chapter 3, I developed a standardized protocol for optimizing the postacquisition processing methods in the MRI to reduce the inter-rater variance. I sought to
systematically identify sources of variability in WMH-VQ techniques that created
challenges for both inter and intra site studies in terms of data comparisons and inference.
My study successfully identified the sources of variability, which included specifying the
center of the image, software compatibility, method of intensity thresholding, and manual
editing. Accordingly, a standardized protocol was presented to minimize the potential
sources of bias and variability in WMH volume quantification. While the developed
protocol was found to be optimal for use in the present dataset for the detection of
subcortical white matter disease, many other protocols exist in the field. Therefore, this
protocol may have unique attributes to other specific studies.
In Chapter 4, I participated in the data collection using the hybrid NIRS/DCS
instrument in cognitive healthy older subjects with high or low risk for developing CVD.
My major contribution was to analyze data, summarize results, and draw conclusions. I
found that at resting baseline LFO gains in the high-risk group were relatively lower
compared to the low-risk group. The lower baseline gains in the high-risk group may
attribute to compensatory mechanisms to maintain stronger steady-state CAs. However,
HUT resulted in smaller gain reductions in the high-risk group compared to the low-risk
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group, suggesting weaker dynamic CAs. Based on these results, LFO gains are potentially
valuable biomarkers for early detection of CSVD based on associations with CAs.
In Chapter 5, I successfully adapted and optimized a fast DCS technique with a
software correlator to increase the sampling rate of DCS measurements up to 20 Hz. I also
used a parallel detection technique to increase the sampling rate of NIRS/DCS
measurements up to 10 Hz. In addition, I designed a new optical probe to overcome hair
influence on DCS measurements for the quantification of CBF on the occipital lobe with
hairs.
6.2

Study Limitations and Future Perspectives
There are some limitations in the present study that need to be addressed in future

studies. In the current work, the MRI post-processing analysis is semi-automated and timeconsuming. Accordingly, moving the method to a fully automatic used in distinct and large
cohorts are needed to extend our findings and reduces the sources-of-variability. Moreover,
we also need to apply our standardized method (Chapter 3) to longitudinal volumetric
studies for tracking dynamic changes of WMHs for an advance understanding of the WM
lesions.
Current fiber-optic probe on the occipital lobe enables collection of CBF data alone.
We will explore integration of NIRS and DCS probes to measure multiple cerebral
hemodynamic parameters simultaneously. While HUT creates orthostatic stress to
challenge the CA, it may also cause syncope, as observed from one participant in our study.
We will explore other noninvasive stimuli (e.g., memory tests, CO2 inhalations) for
challenging the CA to avoid the syncope during HUT.
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Future work employing concurrent measurements could allow a comprehensive
assessment capturing both MRI, which has a high spatial resolution and NIRS/DCS, which
has a high temporal resolution. The optical techniques presented in this dissertation is the
CA study, which used a tilting bed to induce CBF and MAP changes to enhance the optical
measurement, that is simply incompatible with MRI machine. The technological
developments in this dissertation have improved NIRS/DCS techniques to the point where
compatible subject positioning is not an issue for simultaneous measurement. Our further
experiments will expand on this to explore CSVD changes related to cerebral amyloid
angiopathy using both techniques concurrently.
Finally, our studies represent preliminary pilot data that need to be considered with
the caveats that the sample size was not large enough to draw definitive conclusions
regarding physiological explanations for many of the findings presented. We plan to study
more subjects with the improved instruments and experimental protocols in the future to
draw solid conclusions.
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APPENDIX: GLOSSARY

Notations/terms

Descriptions

3D

Three dimensional

[Hb]

Deoxy-hemoglobin concentration

[HbO2]

Oxy-hemoglobin concentration

αDB

Blood flow index (BFI)

Τ

Correlation delay time

Μa

Absorption coefficient

μs’

Reduced scattering coefficient

ADNI

Alzheimer’s disease neuroimaging
initiative

AD

Alzheimer’s disease

ADC

Alzheimer’s disease Center

APD

Avalanche photodiode

ASL

Arterial spin labeling

BET

Brain extraction tool

BOLD

Blood oxygen level-dependent signals

CA

Cerebral autoregulation system

CAA

Cerebral amyloid angiopathy

CCTS

Center for clinical and translational
science

CBF

Cerebral blood flow

CBFV

Cerebral blood flow velocity
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CO2

Carbon dioxide

CoG

Center of gravity

CSF

Cerebral spinal fluid

CT-scan

Computed tomography scan

CVD

Cerebrovascular disease

CW

Continuous wave

DCS

Diffuse correlation spectroscopy

dWMH

Deep white matter hyperintensity

FA

Flip angle

FLAIR

Fluid-attenuated inversion recovery;

fMRI

Functional MRI

GM

Gray matter

H+

Hydrogen

Hb

Deoxy-hemoglobin

HbO2

Oxy-hemoglobin

HUT

Head-up tilting

ICBM

International consortium for brain
mapping

IR

Inversion recovery time

IRB

Institutional review board (IRB)

LFO

Low-frequency oscillation

MAP

Mean arterial pressure

MCI

Mild cognitive impairment
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Medical image processing analysis and
visualization
Magnetization-prepared rapid-acquisition
gradient echo

MIPAV
MPRAGE
MRI

Magnetic resonance imaging

N2

Nitrogen

NIRS

Near-infrared spectroscopy

PAD

Peripheral arterial disease

PASL

Pulsed arterial-spin-labeling

PD

Percentage difference

PET

Positron emission tomography

PSD

Power spectral density

pWMH

Periventricular white matter
hyperintensity

rCBF

Relative changes in cerebral blood flow

ROI

Region of interest

S-D

Source-detector

SCVD

Small cerebrovascular disease

SD

Standard deviation

SE

Standard error of the mean

SPECT

Single positron emission computed
tomography

SWI

Susceptibility-weighted imaging

SNR

Signal-to-noise ratio

TCD

Transcranial Doppler ultrasound
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TE

Echo time

TIV

Total intracranial volume

TR

Repetition time

TTL

Transistor-transistor logic

UK

University of Kentucky

WM

White matter

WMHs

White matter hyperintensities

WMH-VQ

White matter hyperintensity volume
quantification
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